2016 -- S 3013 SUBSTITUTE A | |
======== | |
LC005936/SUB A | |
======== | |
STATE OF RHODE ISLAND | |
IN GENERAL ASSEMBLY | |
JANUARY SESSION, A.D. 2016 | |
____________ | |
A N A C T | |
RELATING TO HEALTH AND SAFETY - UTILIZATION REVIEW | |
| |
Introduced By: Senator Roger Picard | |
Date Introduced: May 19, 2016 | |
Referred To: Senate Health & Human Services | |
It is enacted by the General Assembly as follows: | |
1 | SECTION 1. Chapter 23-17.12 of the General Laws entitled "Health Care Services - |
2 | Utilization Review Act" is hereby repealed in its entirety. |
3 | CHAPTER 23-17.12 |
4 | Health Care Services - Utilization Review Act |
5 | 23-17.12-1. Purpose of chapter. -- The purpose of the chapter is to: |
6 | (1) Promote the delivery of quality health care in a cost effective manner; |
7 | (2) Foster greater coordination between health care providers, patients, payors and |
8 | utilization review entities; |
9 | (3) Protect patients, businesses, and providers by ensuring that review agents are |
10 | qualified to perform utilization review activities and to make informed decisions on the |
11 | appropriateness of medical care; and |
12 | (4) Ensure that review agents maintain the confidentiality of medical records in |
13 | accordance with applicable state and federal laws. |
14 | 23-17.12-2. Definitions. -- As used in this chapter, the following terms are defined as |
15 | follows: |
16 | (1) "Adverse determination" means a utilization review decision by a review agent not to |
17 | authorize a health care service. A decision by a review agent to authorize a health care service in |
18 | an alternative setting, a modified extension of stay, or an alternative treatment shall not constitute |
19 | an adverse determination if the review agent and provider are in agreement regarding the |
| |
1 | decision. Adverse determinations include decisions not to authorize formulary and nonformulary |
2 | medication. |
3 | (2) "Appeal" means a subsequent review of an adverse determination upon request by a |
4 | patient or provider to reconsider all or part of the original decision. |
5 | (3) "Authorization" means the review agent's utilization review, performed according to |
6 | subsection 23-17.12-2(20), concluded that the allocation of health care services of a provider, |
7 | given or proposed to be given to a patient was approved or authorized. |
8 | (4) "Benefit determination" means a decision of the enrollee's entitlement to payment for |
9 | covered health care services as defined in an agreement with the payor or its delegate. |
10 | (5) "Certificate" means a certificate of registration granted by the director to a review |
11 | agent. |
12 | (6) "Complaint" means a written expression of dissatisfaction by a patient, or provider. |
13 | The appeal of an adverse determination is not considered a complaint. |
14 | (7) "Concurrent assessment" means an assessment of the medical necessity and/or |
15 | appropriateness of health care services conducted during a patient's hospital stay or course of |
16 | treatment. If the medical problem is ongoing, this assessment may include the review of services |
17 | after they have been rendered and billed. This review does not mean the elective requests for |
18 | clarification of coverage or claims review or a provider's internal quality assurance program |
19 | except if it is associated with a health care financing mechanism. |
20 | (8) "Department" means the department of health. |
21 | (9) "Director" means the director of the department of health. |
22 | (10) "Emergent health care services" has the same meaning as that meaning contained in |
23 | the rules and regulations promulgated pursuant to chapter 12.3 of title 42 as may be amended |
24 | from time to time and includes those resources provided in the event of the sudden onset of a |
25 | medical, mental health, or substance abuse or other health care condition manifesting itself by |
26 | acute symptoms of a severity (e.g. severe pain) where the absence of immediate medical attention |
27 | could reasonably be expected to result in placing the patient's health in serious jeopardy, serious |
28 | impairment to bodily or mental functions, or serious dysfunction of any body organ or part. |
29 | (11) "Patient" means an enrollee or participant in all hospital or medical plans seeking |
30 | health care services and treatment from a provider. |
31 | (12) "Payor" means a health insurer, self-insured plan, nonprofit health service plan, |
32 | health insurance service organization, preferred provider organization, health maintenance |
33 | organization or other entity authorized to offer health insurance policies or contracts or pay for |
34 | the delivery of health care services or treatment in this state. |
| LC005936/SUB A - Page 2 of 45 |
1 | (13) "Practitioner" means any person licensed to provide or otherwise lawfully providing |
2 | health care services, including, but not limited to, a physician, dentist, nurse, optometrist, |
3 | podiatrist, physical therapist, clinical social worker, or psychologist. |
4 | (14) "Prospective assessment" means an assessment of the medical necessity and/or |
5 | appropriateness of health care services prior to services being rendered. |
6 | (15) "Provider" means any health care facility, as defined in § 23-17-2 including any |
7 | mental health and/or substance abuse treatment facility, physician, or other licensed practitioners |
8 | identified to the review agent as having primary responsibility for the care, treatment, and |
9 | services rendered to a patient. |
10 | (16) "Retrospective assessment" means an assessment of the medical necessity and/or |
11 | appropriateness of health care services that have been rendered. This shall not include reviews |
12 | conducted when the review agency has been obtaining ongoing information. |
13 | (17) "Review agent" means a person or entity or insurer performing utilization review |
14 | that is either employed by, affiliated with, under contract with, or acting on behalf of: |
15 | (i) A business entity doing business in this state; |
16 | (ii) A party that provides or administers health care benefits to citizens of this state, |
17 | including a health insurer, self-insured plan, non-profit health service plan, health insurance |
18 | service organization, preferred provider organization or health maintenance organization |
19 | authorized to offer health insurance policies or contracts or pay for the delivery of health care |
20 | services or treatment in this state; or |
21 | (iii) A provider. |
22 | (18) "Same or similar specialty" means a practitioner who has the appropriate training |
23 | and experience that is the same or similar as the attending provider in addition to experience in |
24 | treating the same problems to include any potential complications as those under review. |
25 | (19) "Urgent health care services" has the same meaning as that meaning contained in |
26 | the rules and regulations promulgated pursuant to chapter 12.3 of title 42 as may be amended |
27 | from time to time and includes those resources necessary to treat a symptomatic medical, mental |
28 | health, or substance abuse or other health care condition requiring treatment within a twenty-four |
29 | (24) hour period of the onset of such a condition in order that the patient's health status not |
30 | decline as a consequence. This does not include those conditions considered to be emergent |
31 | health care services as defined in subdivision (10). |
32 | (20) "Utilization review" means the prospective, concurrent, or retrospective assessment |
33 | of the necessity and/or appropriateness of the allocation of health care services of a provider, |
34 | given or proposed to be given to a patient. Utilization review does not include: |
| LC005936/SUB A - Page 3 of 45 |
1 | (i) Elective requests for the clarification of coverage; or |
2 | (ii) Benefit determination; or |
3 | (iii) Claims review that does not include the assessment of the medical necessity and |
4 | appropriateness; or |
5 | (iv) A provider's internal quality assurance program except if it is associated with a |
6 | health care financing mechanism; or |
7 | (v) The therapeutic interchange of drugs or devices by a pharmacy operating as part of a |
8 | licensed inpatient health care facility; or |
9 | (vi) The assessment by a pharmacist licensed pursuant to the provisions of chapter 19 of |
10 | title 5 and practicing in a pharmacy operating as part of a licensed inpatient health care facility in |
11 | the interpretation, evaluation and implementation of medical orders, including assessments and/or |
12 | comparisons involving formularies and medical orders. |
13 | (21) "Utilization review plan" means a description of the standards governing utilization |
14 | review activities performed by a private review agent. |
15 | (22) "Health care services" means and includes an admission, diagnostic procedure, |
16 | therapeutic procedure, treatment, extension of stay, the ordering and/or filling of formulary or |
17 | nonformulary medications, and any other services, activities, or supplies that are covered by the |
18 | patient's benefit plan. |
19 | (23) "Therapeutic interchange" means the interchange or substitution of a drug with a |
20 | dissimilar chemical structure within the same therapeutic or pharmacological class that can be |
21 | expected to have similar outcomes and similar adverse reaction profiles when given in equivalent |
22 | doses, in accordance with protocols approved by the president of the medical staff or medical |
23 | director and the director of pharmacy. |
24 | 23-17.12-3. General certificate requirements. -- (a) A review agent shall not conduct |
25 | utilization review in the state unless the department has granted the review agent a certificate. |
26 | (b) Individuals shall not be required to hold separate certification under this chapter |
27 | when acting as either an employee of, an affiliate of, a contractor for, or otherwise acting on |
28 | behalf of a certified review agent. |
29 | (c) The department shall issue a certificate to an applicant that has met the minimum |
30 | standards established by this chapter, and regulations promulgated in accordance with it, |
31 | including the payment of any fees as required, and other applicable regulations of the department. |
32 | (d) A certificate issued under this chapter is not transferable, and the transfer of fifty |
33 | percent (50%) or more of the ownership of a review agent shall be deemed a transfer. |
34 | (e) After consultation with the payors and providers of health care, the department shall |
| LC005936/SUB A - Page 4 of 45 |
1 | adopt regulations necessary to implement the provisions of this chapter. |
2 | (f) The director of health is authorized to establish any fees for initial application, |
3 | renewal applications, and any other administrative actions deemed necessary by the director to |
4 | implement this chapter. |
5 | (g) The total cost of certification under this title shall be borne by the certified entities |
6 | and shall be one hundred and fifty percent (150%) of the total salaries paid to the certifying |
7 | personnel of the department engaged in those certifications less any salary reimbursements and |
8 | shall be paid to the director to and for the use of the department. That assessment shall be in |
9 | addition to any taxes and fees otherwise payable to the state. |
10 | (h) The application and other fees required under this chapter shall be sufficient to pay |
11 | for the administrative costs of the certificate program and any other reasonable costs associated |
12 | with carrying out the provisions of this chapter. |
13 | (i) A certificate expires on the second anniversary of its effective date unless the |
14 | certificate is renewed for a two (2) year term as provided in this chapter. |
15 | (j) Any systemic changes in the review agents operations relative to certification |
16 | information on file shall be submitted to the department for approval within thirty (30) days prior |
17 | to implementation. |
18 | 23-17.12-4. Application process. -- (a) An applicant requesting certification or |
19 | recertification shall: |
20 | (1) Submit an application provided by the director; and |
21 | (2) Pay the application fee established by the director through regulation and § 23-17.12- |
22 | 3(f). |
23 | (b) The application shall: |
24 | (1) Be on a form and accompanied by supporting documentation that the director |
25 | requires; and |
26 | (2) Be signed and verified by the applicant. |
27 | (c) Before the certificate expires, a certificate may be renewed for an additional two (2) |
28 | years. |
29 | (d) If a completed application for recertification is being processed by the department, a |
30 | certificate may be continued until a renewal determination is made. |
31 | (e) In conjunction with the application, the review agent shall submit information that |
32 | the director requires including: |
33 | (1) A request that the state agency regard specific portions of the standards and criteria |
34 | or the entire document to constitute "trade secrets" within the meaning of that term in § 38-2- |
| LC005936/SUB A - Page 5 of 45 |
1 | 2(4)(i)(B); |
2 | (2) The policies and procedures to ensure that all applicable state and federal laws to |
3 | protect the confidentiality of individual medical records are followed; |
4 | (3) A copy of the materials used to inform enrollees of the requirements under the health |
5 | benefit plan for seeking utilization review or pre-certification and their rights under this chapter, |
6 | including information on appealing adverse determinations; |
7 | (4) A copy of the materials designed to inform applicable patients and providers of the |
8 | requirements of the utilization review plan; |
9 | (5) A list of the third party payors and business entities for which the review agent is |
10 | performing utilization review in this state and a brief description of the services it is providing for |
11 | each client; and |
12 | (6) Evidence of liability insurance or of assets sufficient to cover potential liability. |
13 | (f) The information provided must demonstrate that the review agent will comply with |
14 | the regulations adopted by the director under this chapter. |
15 | 23-17.12-5. General application requirements. -- An application for certification or |
16 | recertification shall be accompanied by documentation to evidence the following: |
17 | (1) The requirement that the review agent provide patients and providers with a summary |
18 | of its utilization review plan including a summary of the standards, procedures and methods to be |
19 | used in evaluating proposed or delivered health care services; |
20 | (2) The circumstances, if any, under which utilization review may be delegated to any |
21 | other utilization review program and evidence that the delegated agency is a certified utilization |
22 | review agency delegated to perform utilization review pursuant to all of the requirements of this |
23 | chapter; |
24 | (3) A complaint resolution process consistent with subsection 23-17.12-2(6) and |
25 | acceptable to the department, whereby patients, their physicians, or other health care providers |
26 | may seek resolution of complaints and other matters of which the review agent has received |
27 | written notice; |
28 | (4) The type and qualifications of personnel (employed or under contract) authorized to |
29 | perform utilization review, including a requirement that only a practitioner with the same license |
30 | status as the ordering practitioner, or a licensed physician or dentist, is permitted to make a |
31 | prospective or concurrent adverse determination; |
32 | (5) The requirement that a representative of the review agent is reasonably accessible to |
33 | patients, patient's family and providers at least five (5) days a week during normal business in |
34 | Rhode Island and during the hours of the agency's review operations; |
| LC005936/SUB A - Page 6 of 45 |
1 | (6) The policies and procedures to ensure that all applicable state and federal laws to |
2 | protect the confidentiality of individual medical records are followed; |
3 | (7) The policies and procedures regarding the notification and conduct of patient |
4 | interviews by the review agent; |
5 | (8) The requirement that no employee of, or other individual rendering an adverse |
6 | determination for, a review agent may receive any financial incentives based upon the number of |
7 | denials of certification made by that employee or individual; |
8 | (9) The requirement that the utilization review agent shall not impede the provision of |
9 | health care services for treatment and/or hospitalization or other use of a provider's services or |
10 | facilities for any patient; |
11 | (10) Evidence that the review agent has not entered into a compensation agreement or |
12 | contract with its employees or agents whereby the compensation of its employees or its agents is |
13 | based upon a reduction of services or the charges for those services, the reduction of length of |
14 | stay, or utilization of alternative treatment settings; provided, nothing in this chapter shall prohibit |
15 | agreements and similar arrangements; and |
16 | (11) An adverse determination and internal appeals process consistent with § 23-17.12-9 |
17 | and acceptable to the department, whereby patients, their physicians, or other health care |
18 | providers may seek prompt reconsideration or appeal of adverse determinations by the review |
19 | agent. |
20 | 23-17.12-6. Denial, suspension, or revocation of certificate. -- (a) The department may |
21 | deny a certificate upon review of the application if, upon review of the application, it finds that |
22 | the applicant proposing to conduct utilization review does not meet the standards required by this |
23 | chapter or by any regulations promulgated pursuant to this chapter. |
24 | (b) The department may revoke a certificate and/or impose reasonable monetary |
25 | penalties not to exceed five thousand dollars ($5,000) per violation in any case in which: |
26 | (1) The review agent fails to comply substantially with the requirements of this chapter |
27 | or of regulations adopted pursuant to this chapter; |
28 | (2) The review agent fails to comply with the criteria used by it in its application for a |
29 | certificate; or |
30 | (3) The review agent refuses to permit examination by the director to determine |
31 | compliance with the requirements of this chapter and regulations promulgated pursuant to the |
32 | authority granted to the director in this chapter; provided, however, that the examination shall be |
33 | subject to the confidentiality and "need to know" provisions of subdivisions 23-17.12-9(c)(4) and |
34 | (5). These determinations may involve consideration of any written grievances filed with the |
| LC005936/SUB A - Page 7 of 45 |
1 | department against the review agent by patients or providers. |
2 | (c) Any applicant or certificate holder aggrieved by an order or a decision of the |
3 | department made under this chapter without a hearing may, within thirty (30) days after notice of |
4 | the order or decision, make a written request to the department for a hearing on the order or |
5 | decision pursuant to § 42-35-15. |
6 | (d) The procedure governing hearings authorized by this section shall be in accordance |
7 | with §§ 42-35-9 -- 42-35-13 as stipulated in § 42-35-14(a). A full and complete record shall be |
8 | kept of all proceedings, and all testimony shall be recorded but need not be transcribed unless the |
9 | decision is appealed pursuant to § 42-35-15. A copy or copies of the transcript may be obtained |
10 | by any interested party upon payment of the cost of preparing the copy or copies. Witnesses may |
11 | be subpoenaed by either party. |
12 | 23-17.12-7. Judicial review. -- Any person who has exhausted all administrative |
13 | remedies available to him or her within the department, and who is aggrieved by a final decision |
14 | of the department under § 23-17.12-6, is entitled to judicial review pursuant to §§ 42-35-15 and |
15 | 42-35-16. |
16 | 23-17.12-8. Waiver of requirements. -- (a) Except for utilization review agencies |
17 | performing utilization review activities to determine the necessity and/or appropriateness of |
18 | substance abuse and mental health care, treatment or services, the department shall waive all the |
19 | requirements of this chapter, with the exception of those contained in §§ 23-17.12-9, (a)(1)-(3), |
20 | (5), (6), (8), (b)(1)-(6), and (c)(2)-(6), 23-17.12-12, and 23-17.12-14, for a review agent that has |
21 | received, maintains and provides evidence to the department of accreditation from the utilization |
22 | review accreditation commission (URAC) or other organization approved by the director. The |
23 | waiver shall be applicable only to those services that are included under the accreditation by the |
24 | utilization review accreditation commission or other approved organization. |
25 | (b) The department shall waive the requirements of this chapter only when a direct |
26 | conflict exists with those activities of a review agent that are conducted pursuant to contracts with |
27 | the state or the federal government or those activities under other state or federal jurisdictions. |
28 | (c) The limitation in subsection 23-17.12-8(b) notwithstanding, the department may |
29 | waive or exempt all or part of the requirements of this chapter by mutual written agreement with |
30 | a state department or agency when such waiver or exemption is determined to be necessary and |
31 | appropriate to the administration of a health care related program. The department shall |
32 | promulgate such regulations as deemed appropriate to implement this provision. |
33 | 23-17.12-8.1. Variance of statutory requirements. [Repealed effective July 1, 2015.] - |
34 | - (a) The department is authorized to issue a statutory variance from one or more of the specific |
| LC005936/SUB A - Page 8 of 45 |
1 | requirements of this chapter to a review agent where it determines that such variance is necessary |
2 | to permit the review agent to evaluate and address practitioner billing and practice patterns when |
3 | the review agent believes in good faith that such patterns evidence the existence of fraud or |
4 | abuse. Any variance issued by the department pursuant to this section shall be limited in |
5 | application to those services billed directly by the practitioner. Prior to issuing a statutory |
6 | variance the department shall provide notice and a public hearing to ensure necessary patient and |
7 | health care provider protections in the process. Statutory variances shall be issued for a period not |
8 | to exceed one year and may be subject to such terms and conditions deemed necessary by the |
9 | department. |
10 | (b) On or before January 15th of each year, the department shall issue a report to the |
11 | general assembly summarizing any review agent activity as a result of a waiver granted under the |
12 | provisions of this section. |
13 | 23-17.12-9. Review agency requirement for adverse determination and internal |
14 | appeals. -- (a) The adverse determination and appeals process of the review agent shall conform |
15 | to the following: |
16 | (1) Notification of a prospective adverse determination by the review agent shall be |
17 | mailed or otherwise communicated to the provider of record and to the patient or other |
18 | appropriate individual as follows: |
19 | (i) Within fifteen (15) business days of receipt of all the information necessary to |
20 | complete a review of non-urgent and/or non-emergent services; |
21 | (ii) Within seventy-two (72) hours of receipt of all the information necessary to complete |
22 | a review of urgent and/or emergent services; and |
23 | (iii) Prior to the expected date of service. |
24 | (2) Notification of a concurrent adverse determination shall be mailed or otherwise |
25 | communicated to the patient and to the provider of record period as follows: |
26 | (i) To the provider(s) prior to the end of the current certified period; and |
27 | (ii) To the patient within one business day of making the adverse determination. |
28 | (3) Notification of a retrospective adverse determination shall be mailed or otherwise |
29 | communicated to the patient and to the provider of record within thirty (30) business days of |
30 | receipt of a request for payment with all supporting documentation for the covered benefit being |
31 | reviewed. |
32 | (4) A utilization review agency shall not retrospectively deny authorization for health |
33 | care services provided to a covered person when an authorization has been obtained for that |
34 | service from the review agent unless the approval was based upon inaccurate information |
| LC005936/SUB A - Page 9 of 45 |
1 | material to the review or the health care services were not provided consistent with the provider's |
2 | submitted plan of care and/or any restrictions included in the prior approval granted by the review |
3 | agent. |
4 | (5) Any notice of an adverse determination shall include: |
5 | (i) The principal reasons for the adverse determination, to include explicit documentation |
6 | of the criteria not met and/or the clinical rationale utilized by the agency's clinical reviewer in |
7 | making the adverse determination. The criteria shall be in accordance with the agency criteria |
8 | noted in subsection 23-17.12-9(d) and shall be made available within the first level appeal |
9 | timeframe if requested unless otherwise provided as part of the adverse determination notification |
10 | process; |
11 | (ii) The procedures to initiate an appeal of the adverse determination, including the name |
12 | and telephone number of the person to contract with regard to an appeal; |
13 | (iii) The necessary contact information to complete the two-way direct communication |
14 | defined in subdivision 23-17.12-9(a)(7); and |
15 | (iv) The information noted in subdivision 23-27.12-9(a)(5)(i)(ii)(iii) for all verbal |
16 | notifications followed by written notification to the patient and provider(s). |
17 | (6) All initial retrospective adverse determinations of a health care service that had been |
18 | ordered by a physician, dentist or other practitioner shall be made, documented and signed |
19 | consistent with the regulatory requirements which shall be developed by the department with the |
20 | input of review agents, providers and other affected parties. |
21 | (7) A level one appeal decision of an adverse determination shall not be made until an |
22 | appropriately qualified and licensed review physician, dentist or other practitioner has spoken to, |
23 | or otherwise provided for, an equivalent two-way direct communication with the patient's |
24 | attending physician, dentist, other practitioner, other designated or qualified professional or |
25 | provider responsible for treatment of the patient concerning the medical care, with the exception |
26 | of the following: |
27 | (i) When the attending provider is not reasonably available; |
28 | (ii) When the attending provider chooses not to speak with agency staff; |
29 | (iii) When the attending provider has negotiated an agreement with the review agent for |
30 | alternative care; and/or |
31 | (iv) When the attending provider requests a peer to peer communication prior to the |
32 | adverse determination, the review agency shall then comply with subdivision 23-17.12-9(c)(1) in |
33 | responding to such a request. Such requests shall be on the case specific basis unless otherwise |
34 | arranged for in advance by the provider. |
| LC005936/SUB A - Page 10 of 45 |
1 | (8) All initial, prospective and concurrent adverse determinations of a health care service |
2 | that had been ordered by a physician, dentist or other practitioner shall be made, documented and |
3 | signed by a licensed practitioner with the same licensure status as the ordering practitioner or a |
4 | licensed physician or dentist. This does not prohibit appropriately qualified review agency staff |
5 | from engaging in discussions with the attending provider, the attending provider's designee or |
6 | appropriate health care facility and office personnel regarding alternative service and treatment |
7 | options. Such a discussion shall not constitute an adverse determination provided though that any |
8 | change to the provider's original order and/or any decision for an alternative level of care must be |
9 | made and/or appropriately consented to by the attending provider or the provider's designee |
10 | responsible for treating the patient. |
11 | (9) The requirement that, upon written request made by or on behalf of a patient, any |
12 | adverse determination and/or appeal shall include the written evaluation and findings of the |
13 | reviewing physician, dentist or other practitioner. The review agent is required to accept a verbal |
14 | request made by or on behalf of a patient for any information where a provider or patient can |
15 | demonstrate that a timely response is urgent. |
16 | (b) The review agent shall conform to the following for the appeal of an adverse |
17 | determination: |
18 | (1) The review agent shall maintain and make available a written description of the |
19 | appeal procedure by which either the patient or the provider of record may seek review of |
20 | determinations not to authorize a health care service. The process established by each review |
21 | agent may include a reasonable period within which an appeal must be filed to be considered and |
22 | that period shall not be less than sixty (60) days. |
23 | (2) The review agent shall notify, in writing, the patient and provider of record of its |
24 | decision on the appeal as soon as practical, but in no case later than fifteen (15) or twenty-one |
25 | (21) business days if verbal notice is given within fifteen (15) business days after receiving the |
26 | required documentation on the appeal. |
27 | (3) The review agent shall also provide for an expedited appeals process for emergency |
28 | or life threatening situations. Each review agent shall complete the adjudication of expedited |
29 | appeals within two (2) business days of the date the appeal is filed and all information necessary |
30 | to complete the appeal is received by the review agent. |
31 | (4) All first level appeals of determinations not to authorize a health care service that had |
32 | been ordered by a physician, dentist, or other practitioner shall be made, documented, and signed |
33 | by a licensed practitioner with the same licensure status as the ordering practitioner or a licensed |
34 | physician or a licensed dentist. |
| LC005936/SUB A - Page 11 of 45 |
1 | (5) All second level appeal decisions shall be made, signed, and documented by a |
2 | licensed practitioner in the same or a similar general specialty as typically manages the medical |
3 | condition, procedure, or treatment under discussion. |
4 | (6) The review agent shall maintain records of written appeals and their resolution, and |
5 | shall provide reports as requested by the department. |
6 | (c) The review agency must conform to the following requirements when making its |
7 | adverse determination and appeal decisions: |
8 | (1) The review agent must assure that the licensed practitioner or licensed physician is |
9 | reasonably available to review the case as required under subdivision 23-17.12-9(a)(7) and shall |
10 | conform to the following: |
11 | (i) Each agency peer reviewer shall have access to and review all necessary information |
12 | as requested by the agency and/or submitted by the provider(s) and/or patients; |
13 | (ii) Each agency shall provide accurate peer review contact information to the provider at |
14 | the time of service, if requested, and/or prior to such service, if requested. This contact |
15 | information must provide a mechanism for direct communication with the agency's peer |
16 | reviewer; |
17 | (iii) Agency peer reviewers shall respond to the provider's request for a two-way direct |
18 | communication defined in subdivision 23-17.12-9(a)(7)(iv) as follows: |
19 | (A) For a prospective review of non-urgent and non-emergent health care services, a |
20 | response within one business day of the request for a peer discussion; |
21 | (B) For concurrent and prospective reviews of urgent and emergent health care services, |
22 | a response within a reasonable period of time of the request for a peer discussion; and |
23 | (C) For retrospective reviews, prior to the first level appeal decision. |
24 | (iv) The review agency will have met the requirements of a two-way direct |
25 | communication, when requested and/or as required prior to the first level of appeal, when it has |
26 | made two (2) reasonable attempts to contact the attending provider directly. |
27 | (v) Repeated violations of this section shall be deemed to be substantial violations |
28 | pursuant to § 23-17.12-14 and shall be cause for the imposition of penalties under that section. |
29 | (2) No reviewer at any level under this section shall be compensated or paid a bonus or |
30 | incentive based on making or upholding an adverse determination. |
31 | (3) No reviewer under this section who has been involved in prior reviews of the case |
32 | under appeal or who has participated in the direct care of the patient may participate as the sole |
33 | reviewer in reviewing a case under appeal; provided, however, that when new information has |
34 | been made available at the first level of appeal, then the review may be conducted by the same |
| LC005936/SUB A - Page 12 of 45 |
1 | reviewer who made the initial adverse determination. |
2 | (4) A review agent is only entitled to review information or data relevant to the |
3 | utilization review process. A review agent may not disclose or publish individual medical records |
4 | or any confidential medical information obtained in the performance of utilization review |
5 | activities. A review agent shall be considered a third party health insurer for the purposes of § 5- |
6 | 37.3-6(b)(6) of this state and shall be required to maintain the security procedures mandated in § |
7 | 5-37.3-4(c). |
8 | (5) Notwithstanding any other provision of law, the review agent, the department, and all |
9 | other parties privy to information which is the subject of this chapter shall comply with all state |
10 | and federal confidentiality laws, including, but not limited to, chapter 37.3 of title 5 |
11 | (Confidentiality of Health Care Communications and Information Act) and specifically § 5-37.3- |
12 | 4(c), which requires limitation on the distribution of information which is the subject of this |
13 | chapter on a "need to know" basis, and § 40.1-5-26. |
14 | (6) The department may, in response to a complaint that is provided in written form to |
15 | the review agent, review an appeal regarding any adverse determination, and may request |
16 | information of the review agent, provider or patient regarding the status, outcome or rationale |
17 | regarding the decision. |
18 | (d) The requirement that each review agent shall utilize and provide upon request, by |
19 | Rhode Island licensed hospitals and the Rhode Island Medical Society, in either electronic or |
20 | paper format, written medically acceptable screening criteria and review procedures which are |
21 | established and periodically evaluated and updated with appropriate consultation with Rhode |
22 | Island licensed physicians, hospitals, including practicing physicians, and other health care |
23 | providers in the same specialty as would typically treat the services subject to the criteria as |
24 | follows: |
25 | (1) Utilization review agents shall consult with no fewer than five (5) Rhode Island |
26 | licensed physicians or other health care providers. Further, in instances where the screening |
27 | criteria and review procedures are applicable to inpatients and/or outpatients of hospitals, the |
28 | medical director of each licensed hospital in Rhode Island shall also be consulted. Utilization |
29 | review agents who utilize screening criteria and review procedures provided by another entity |
30 | may satisfy the requirements of this section if the utilization review agent demonstrates to the |
31 | satisfaction of the director that the entity furnishing the screening criteria and review procedures |
32 | has complied with the requirements of this section. |
33 | (2) Utilization review agents seeking initial certification shall conduct the consultation |
34 | for all screening and review criteria to be utilized. Utilization review agents who have been |
| LC005936/SUB A - Page 13 of 45 |
1 | certified for one year or longer shall be required to conduct the consultation on a periodic basis |
2 | for the utilization review agent's highest volume services subject to utilization review during the |
3 | prior year; services subject to the highest volume of adverse determinations during the prior year; |
4 | and for any additional services identified by the director. |
5 | (3) Utilization review agents shall not include in the consultations as required under |
6 | paragraph (1) of this subdivision, any physicians or other health services providers who have |
7 | financial relationships with the utilization review agent other than financial relationships for |
8 | provisions of direct patient care to utilization review agent enrollees and reasonable compensation |
9 | for consultation as required by paragraph (1) of this subdivision. |
10 | (4) All documentation regarding required consultations, including comments and/or |
11 | recommendations provided by the health care providers involved in the review of the screening |
12 | criteria, as well as the utilization review agent's action plan or comments on any |
13 | recommendations, shall be in writing and shall be furnished to the department on request. The |
14 | documentation shall also be provided on request to any licensed health care provider at a nominal |
15 | cost that is sufficient to cover the utilization review agent's reasonable costs of copying and |
16 | mailing. |
17 | (5) Utilization review agents may utilize non-Rhode Island licensed physicians or other |
18 | health care providers to provide the consultation as required under paragraph (1) of this |
19 | subdivision, when the utilization review agent can demonstrate to the satisfaction of the director |
20 | that the related services are not currently provided in Rhode Island or that another substantial |
21 | reason requires such approach. |
22 | (6) Utilization review agents whose annualized data reported to the department |
23 | demonstrate that the utilization review agent will review fewer than five hundred (500) such |
24 | requests for authorization may request a variance from the requirements of this section. |
25 | 23-17.12-10. External appeal requirements. -- (a) In cases where the second level of |
26 | appeal to reverse an adverse determination is unsuccessful, the review agent shall provide for an |
27 | external appeal by an unrelated and objective appeal agency, selected by the director. The director |
28 | shall promulgate rules and regulations including, but not limited to, criteria for designation, |
29 | operation, policy, oversight, and termination of designation as an external appeal agency. The |
30 | external appeal agency shall not be required to be certified under this chapter for activities |
31 | conducted pursuant to its designation. |
32 | (b) The external appeal shall have the following characteristics: |
33 | (1) The external appeal review and decision shall be based on the medical necessity for |
34 | the health care or service and the appropriateness of service delivery for which authorization has |
| LC005936/SUB A - Page 14 of 45 |
1 | been denied. |
2 | (2) Neutral physicians, dentists, or other practitioners in the same or similar general |
3 | specialty as typically manages the health care service shall be utilized to make the external appeal |
4 | decisions. |
5 | (3) Neutral physicians, dentists, or other practitioners shall be selected from lists: |
6 | (i) Mutually agreed upon by the provider associations, insurers, and the purchasers of |
7 | health services; and |
8 | (ii) Used during a twelve (12) month period as the source of names for neutral physician, |
9 | dentist, or other practitioner reviewers. |
10 | (4) The neutral physician, dentist, or other practitioner may confer either directly with |
11 | the review agent and provider, or with physicians or dentists appointed to represent them. |
12 | (5) Payment for the appeal fee charged by the neutral physician, dentist, or other |
13 | practitioner shall be shared equally between the two (2) parties to the appeal; provided, however, |
14 | that if the decision of the utilization review agent is overturned, the appealing party shall be |
15 | reimbursed by the utilization review agent for their share of the appeal fee paid under this |
16 | subsection. |
17 | (6) The decision of the external appeal agency shall be binding; however, any person |
18 | who is aggrieved by a final decision of the external appeal agency is entitled to judicial review in |
19 | a court of competent jurisdiction. |
20 | 23-17.12-11. Repealed.. -- |
21 | 23-17.12-12. Reporting requirements. -- (a) The department shall establish reporting |
22 | requirements to determine if the utilization review programs are in compliance with the |
23 | provisions of this chapter and applicable regulations. |
24 | (b) By November 14, 2014, the department shall report to the general assembly |
25 | regarding hospital admission practices and procedures and the effects of such practices and |
26 | procedures on the care and wellbeing of patients who present behavioral healthcare conditions on |
27 | an emergency basis. The report shall be developed with the cooperation of the department of |
28 | behavioral healthcare, developmental disabilities, and hospitals and of the department of children, |
29 | youth, and families, and shall recommend changes to state law and regulation to address any |
30 | necessary and appropriate revisions to the department's regulations related to utilization review |
31 | based on the Federal Mental Health Parity and Addiction Equity Act of 2008 (MHPAEA) and the |
32 | Patient Protection and Affordable Care Act, Pub. L. 111-148, and the state's regulatory |
33 | interpretation of parity in insurance coverage of behavioral healthcare. These recommended or |
34 | adopted revisions to the department's regulations shall include, but not be limited to: |
| LC005936/SUB A - Page 15 of 45 |
1 | (1) Adverse determination and internal appeals, with particular regard to the time |
2 | necessary to complete a review of urgent and/or emergent services for patients with behavioral |
3 | health needs; |
4 | (2) External appeal requirements; |
5 | (3) The process for investigating whether insurers and agents are complying with the |
6 | provisions of chapter 17.12 of title 23 in light of parity in insurance coverage for behavioral |
7 | healthcare, with particular regard to emergency admissions; and |
8 | (4) Enforcement of the provisions of chapter 17.12 of title 23 in light of insurance parity |
9 | for behavioral healthcare. |
10 | 23-17.12-13. Lists. -- The director shall periodically provide a list of private review |
11 | agents issued certificates and the renewal date for those certificates to all licensed health care |
12 | facilities and any other individual or organization requesting the list. |
13 | 23-17.12-14. Penalties. -- A person who substantially violates any provision of this |
14 | chapter or any regulation adopted under this chapter or who submits any false information in an |
15 | application required by this chapter is guilty of a misdemeanor and on conviction is subject to a |
16 | penalty not exceeding five thousand dollars ($5,000). |
17 | 23-17.12-15. Annual report. -- The director shall issue an annual report to the governor |
18 | and the general assembly concerning the conduct of utilization review in the state. The report |
19 | shall include a description of utilization programs and the services they provide, an analysis of |
20 | complaints filed against private review agents by patients or providers and an evaluation of the |
21 | impact of utilization review programs on patient access to care. |
22 | 23-17.12-16. Fees. -- The proceeds of any fees, monetary penalties, and fines collected |
23 | pursuant to the provisions of this chapter shall be deposited as general revenues. |
24 | . |
25 | 23-17.12-17. Severability. -- If any provision of this chapter or the application of any |
26 | provision to any person or circumstance shall be held invalid, that invalidity shall not affect the |
27 | provisions or application of this chapter which can be given effect without the invalid provision |
28 | or application, and to this end the provisions of this chapter are declared to be severable. |
29 | SECTION 2. Chapter 23-17.13 of the General Laws entitled "Health Care Accessibility |
30 | and Quality Assurance Act" is hereby repealed in its entirety. |
31 | CHAPTER 23-17.13 |
32 | Health Care Accessibility and Quality Assurance Act |
33 | 23-17.13-1. Purpose. -- The legislature declares that: |
34 | (1) It is in the best interest of the public that those individuals and care entities involved |
| LC005936/SUB A - Page 16 of 45 |
1 | with the delivery of plan coverage in our state meet the standards of this chapter to insure |
2 | accessibility and quality for the state's patients; |
3 | (2) Nothing in the legislation is intended to prohibit a health care entity or contractor |
4 | from forming limited networks of providers; and |
5 | (3) It is a vital state function to establish these standards for the conduct of health plans |
6 | by a health care entity in Rhode Island. |
7 | 23-17.13-2. Definitions. -- As used in this chapter: |
8 | (1) "Adverse decision" means any decision by a review agent not to certify an admission, |
9 | service, procedure, or extension of stay. A decision by a reviewing agent to certify an admission, |
10 | service, or procedure in an alternative treatment setting, or to certify a modified extension of stay, |
11 | shall not constitute an adverse decision if the reviewing agent and the requesting provider are in |
12 | agreement regarding the decision. |
13 | (2) "Contractor" means a person/entity that: |
14 | (i) Establishes, operates or maintains a network of participating providers; |
15 | (ii) Contracts with an insurance company, a hospital or medical or dental service plan, an |
16 | employer, whether under written or self insured, an employee organization, or any other entity |
17 | providing coverage for health care services to administer a plan; and/or |
18 | (iii) Conducts or arranges for utilization review activities pursuant to chapter 17.12 of |
19 | this title. |
20 | (3) "Direct service ratio" means the amount of premium dollars expended by the plan for |
21 | covered services provided to enrollees on a plan's fiscal year basis. |
22 | (4) "Director" means the director of the department of health. |
23 | (5) "Emergency services" has the same meaning as the meaning contained in the rules |
24 | and regulations promulgated pursuant to chapter 12.3 of title 42, as may be amended from time to |
25 | time, and includes the sudden onset of a medical or mental condition that the absence of |
26 | immediate medical attention could reasonably be expected to result in placing the patient's health |
27 | in serious jeopardy, serious impairment to bodily or mental functions, or serious dysfunction of |
28 | any bodily organ or part. |
29 | (6) "Health care entity" means a licensed insurance company, hospital, or dental or |
30 | medical service plan or health maintenance organization, or a contractor as described in |
31 | subdivision (2), that operates a health plan. |
32 | (7) "Health care services" includes, but is not limited to, medical, mental health, |
33 | substance abuse, and dental services. |
34 | (8) "Health plan" means a plan operated by a health care entity as described in |
| LC005936/SUB A - Page 17 of 45 |
1 | subdivision (6) that provides for the delivery of care services to persons enrolled in the plan |
2 | through: |
3 | (i) Arrangements with selected providers to furnish health care services; and/or |
4 | (ii) Financial incentives for persons enrolled in the plan to use the participating providers |
5 | and procedures provided for by the plan. |
6 | (9) "Provider" means a physician, hospital, pharmacy, laboratory, dentist, or other state |
7 | licensed or other state recognized provider of health care services or supplies, and whose services |
8 | are recognized pursuant to 213(d) of the Internal Revenue Code, 26 U.S.C. § 213(d), that has |
9 | entered into an agreement with a health care entity as described in subdivision (6) or contractor as |
10 | described in subdivision (2) to provide these services or supplies to a patient enrolled in a plan. |
11 | (10) "Provider incentive plan" means any compensation arrangement between a health |
12 | care entity or plan and a provider or provider group that may directly or indirectly have the effect |
13 | of reducing or limiting services provided with respect to an individual enrolled in a plan. |
14 | (11) "Qualified health plan" means a plan that the director of the department of health |
15 | certified, upon application by the program, as meeting the requirements of this chapter. |
16 | (12) "Qualified utilization review program" means utilization review program that meets |
17 | the requirements of chapter 17.12 of this title. |
18 | (13) "Most favored rate clause" means a provision in a provider contract whereby the |
19 | rates or fees to be paid by a health plan are fixed, established or adjusted to be equal to or lower |
20 | than the rates or fees paid to the provider by any other health plan or third party payor. |
21 | 23-17.13-3. Certification of health plans. -- (a) Certification process. |
22 | (1) Certification. |
23 | (i) The director shall establish a process for certification of health plans meeting the |
24 | requirements of certification in subsection (b). |
25 | (ii) The director shall act upon the health plan's completed application for certification |
26 | within ninety (90) days of receipt of such application for certification. |
27 | (2) Review and recertification. - To ensure compliance with subsection (b), the director |
28 | shall establish procedures for the periodic review and recertification of qualified health plans not |
29 | less than every five (5) years; provided, however, that the director may review the certification of |
30 | a qualified health plan at any time if there exists evidence that a qualified health plan may be in |
31 | violation of subsection (b). |
32 | (3) Cost of certification. - The total cost of obtaining and maintaining certification under |
33 | this title and compliance with the requirements of the applicable rules and regulations are borne |
34 | by the entities so certified and shall be one hundred and fifty percent (150%) of the total salaries |
| LC005936/SUB A - Page 18 of 45 |
1 | paid to the certifying personnel of the department engaged in those certifications less any salary |
2 | reimbursements and shall be paid to the director to and for the use of the department. That |
3 | assessment shall be in addition to any taxes and fees otherwise payable to the state. |
4 | (4) Standard definitions. - To help ensure a patient's ability to make informed decisions |
5 | regarding their health care, the director shall promulgate regulation(s) to provide for standardized |
6 | definitions (unless defined in existing statute) of the following terms in this subdivision, |
7 | provided, however, that no definition shall be construed to require a health care entity to add any |
8 | benefit, to increase the scope of any benefit, or to increase any benefit under any contract: |
9 | (i) Allowable charge; |
10 | (ii) Capitation; |
11 | (iii) Co-payments; |
12 | (iv) Co-insurance; |
13 | (v) Credentialing; |
14 | (vi) Formulary; |
15 | (vii) Grace period; |
16 | (viii) Indemnity insurance; |
17 | (ix) In-patient care; |
18 | (x) Maximum lifetime cap; |
19 | (xi) Medical necessity; |
20 | (xii) Out-of-network; |
21 | (xiii) Out-patient; |
22 | (xiv) Pre-existing conditions; |
23 | (xv) Point of service; |
24 | (xvi) Risk sharing; |
25 | (xvii) Second opinion; |
26 | (xviii) Provider network; |
27 | (xix) Urgent care. |
28 | (b) Requirements for certification. - The director shall establish standards and procedures |
29 | for the certification of qualified health plans that conduct business in this state and who have |
30 | demonstrated the ability to ensure that health care services will be provided in a manner to assure |
31 | availability and accessibility, adequate personnel and facilities, and continuity of service, and has |
32 | demonstrated arrangements for ongoing quality assurance programs regarding care processes and |
33 | outcomes; other standards shall consist of, but are not limited to, the following: |
34 | (1) Prospective and current enrollees in health plans must be provided information as to |
| LC005936/SUB A - Page 19 of 45 |
1 | the terms and conditions of the plan consistent with the rules and regulations promulgated under |
2 | chapter 12.3 of title 42 so that they can make informed decisions about accepting and utilizing the |
3 | health care services of the health plan. This must be standardized so that customers can compare |
4 | the attributes of the plans, and all information required by this paragraph shall be updated at |
5 | intervals determined by the director. Of those items required under this section, the director shall |
6 | also determine which items shall be routinely distributed to prospective and current enrollees as |
7 | listed in this subsection and which items may be made available upon request. The items to be |
8 | disclosed are: |
9 | (i) Coverage provisions, benefits, and any restriction or limitations on health care |
10 | services, including but not limited to, any exclusions as follows: by category of service, and if |
11 | applicable, by specific service, by technology, procedure, medication, provider or treatment |
12 | modality, diagnosis and condition, the latter three (3) of which shall be listed by name. |
13 | (ii) Experimental treatment modalities that are subject to change with the advent of new |
14 | technology may be listed solely by the broad category "Experimental Treatments". The |
15 | information provided to consumers shall include the plan's telephone number and address where |
16 | enrollees may call or write for more information or to register a complaint regarding the plan or |
17 | coverage provision. |
18 | (2) Written statement of the enrollee's right to seek a second opinion, and reimbursement |
19 | if applicable. |
20 | (3) Written disclosure regarding the appeals process described in § 23-17.12-1 et seq. |
21 | and in the rules and regulations for the utilization review of care services, promulgated by the |
22 | department of health, the telephone numbers and addresses for the plan's office which handles |
23 | complaints as well as for the office which handles the appeals process under § 23-17.12-1 et seq. |
24 | and the rules and regulations for the utilization of health. |
25 | (4) Written statement of prospective and current enrollees' right to confidentiality of all |
26 | health care record and information in the possession and/or control of the plan, its employees, its |
27 | agents and parties with whom a contractual agreement exists to provide utilization review or who |
28 | in any way have access to care information. A summary statement of the measures taken by the |
29 | plan to ensure confidentiality of an individual's health care records shall be disclosed. |
30 | (5) Written disclosure of the enrollee's right to be free from discrimination by the health |
31 | plan and the right to refuse treatment without jeopardizing future treatment. |
32 | (6) Written disclosure of a plan's policy to direct enrollees to particular providers. Any |
33 | limitations on reimbursement should the enrollee refuse the referral must be disclosed. |
34 | (7) A summary of prior authorization or other review requirements including |
| LC005936/SUB A - Page 20 of 45 |
1 | preauthorization review, concurrent review, post-service review, post-payment review and any |
2 | procedure that may lead the patient to be denied coverage for or not be provided a particular |
3 | service. |
4 | (8) Any health plan that operates a provider incentive plan shall not enter into any |
5 | compensation agreement with any provider of covered services or pharmaceutical manufacturer |
6 | pursuant to which specific payment is made directly or indirectly to the provider as an |
7 | inducement or incentive to reduce or limit services, to reduce the length of stay or the use of |
8 | alternative treatment settings or the use of a particular medication with respect to an individual |
9 | patient, provided however, that capitation agreements and similar risk sharing arrangements are |
10 | not prohibited. |
11 | (9) Health plans must disclose to prospective and current enrollees the existence of |
12 | financial arrangements for capitated or other risk sharing arrangements that exist with providers |
13 | in a manner described in paragraphs (i), (ii), and (iii): |
14 | (i) "This health plan utilizes capitated arrangements, with its participating providers, or |
15 | contains other similar risk sharing arrangements; |
16 | (ii) This health plan may include a capitated reimbursement arrangement or other similar |
17 | risk sharing arrangement, and other financial arrangements with your provider; |
18 | (iii) This health plan is not capitated and does not contain other risk sharing |
19 | arrangements." |
20 | (10) Written disclosure of criteria for accessing emergency health care services as well |
21 | as a statement of the plan's policies regarding payment for examinations to determine if |
22 | emergency health care services are necessary, the emergency care itself, and the necessary |
23 | services following emergency treatment or stabilization. The health plan must respond to the |
24 | request of the treating provider for post-stabilization treatment by approving or denying it as soon |
25 | as possible. |
26 | (11) Explanation of how health plan limitations impact enrollees, including information |
27 | on enrollee financial responsibility for payment for co-insurance, co-payment, or other non- |
28 | covered, out-of-pocket, or out-of-plan services. This shall include information on deductibles and |
29 | benefits limitations including, but not limited to, annual limits and maximum lifetime benefits. |
30 | (12) The terms under which the health plan may be renewed by the plan enrollee, |
31 | including any reservation by the plan of any right to increase premiums. |
32 | (13) Summary of criteria used to authorize treatment. |
33 | (14) A schedule of revenues and expenses, including direct service ratios and other |
34 | statistical information which meets the requirements set forth below on a form prescribed by the |
| LC005936/SUB A - Page 21 of 45 |
1 | director. |
2 | (15) Plan costs of health care services, including but not limited to all of the following: |
3 | (i) Physician services; |
4 | (ii) Hospital services, including both inpatients and outpatient services; |
5 | (iii) Other professional services; |
6 | (iv) Pharmacy services, excluding pharmaceutical products dispensed in a physician's |
7 | office; |
8 | (v) Health education; |
9 | (vi) Substance abuse services and mental health services. |
10 | (16) Plan complaint, adverse decision, and prior authorization statistics. This statistical |
11 | data shall be updated annually: |
12 | (i) The ratio of the number of complaints received to the total number of covered |
13 | persons, reported by category, listed in paragraphs (b)(15)(i) -- (vi); |
14 | (ii) The ratio of the number of adverse decisions issued to the number of complaints |
15 | received, reported by category; |
16 | (iii) The ratio of the number of prior authorizations denied to the number of prior |
17 | authorizations requested, reported by category; |
18 | (iv) The ratio of the number of successful enrollee appeals to the total number of appeals |
19 | filed. |
20 | (17) Plans must demonstrate that: |
21 | (i) They have reasonable access to providers, so that all covered health care services will |
22 | be provided. This requirement cannot be waived and must be met in all areas where the health |
23 | plan has enrollees; |
24 | (ii) Urgent health care services, if covered, shall be available within a time frame that |
25 | meets standards set by the director. |
26 | (18) A comprehensive list of participating providers listed by office location, specialty if |
27 | applicable, and other information as determined by the director, updated annually. |
28 | (19) Plans must provide to the director, at intervals determined by the director, enrollee |
29 | satisfaction measures. The director is authorized to specify reasonable requirements for these |
30 | measures consistent with industry standards to assure an acceptable degree of statistical validity |
31 | and comparability of satisfaction measures over time and among plans. The director shall publish |
32 | periodic reports for the public providing information on health plan enrollee satisfaction. |
33 | (c) Issuance of certification. |
34 | (1) Upon receipt of an application for certification, the director shall notify and afford |
| LC005936/SUB A - Page 22 of 45 |
1 | the public an opportunity to comment upon the application. |
2 | (2) A health care plan will meet the requirements of certification, subsection (b) by |
3 | providing information required in subsection (b) to any state or federal agency in conformance |
4 | with any other applicable state or federal law, or in conformity with standards adopted by an |
5 | accrediting organization provided that the director determines that the information is substantially |
6 | similar to the previously mentioned requirements and is presented in a format that provides a |
7 | meaningful comparison between health plans. |
8 | (3) All health plans shall be required to establish a mechanism, under which providers, |
9 | including local providers participating in the plan, provide input into the plan's health care policy, |
10 | including technology, medications and procedures, utilization review criteria and procedures, |
11 | quality and credentialing criteria, and medical management procedures. |
12 | (4) All health plans shall be required to establish a mechanism under which local |
13 | individual subscribers to the plan provide input into the plan's procedures and processes regarding |
14 | the delivery of health care services. |
15 | (5) A health plan shall not refuse to contract with or compensate for covered services an |
16 | otherwise eligible provider or non-participating provider solely because that provider has in good |
17 | faith communicated with one or more of his or her patients regarding the provisions, terms or |
18 | requirements of the insurer's products as they relate to the needs of that provider's patients. |
19 | (6) (i) All health plans shall be required to publicly notify providers within the health |
20 | plans' geographic service area of the opportunity to apply for credentials. This notification |
21 | process shall be required only when the plan contemplates adding additional providers and may |
22 | be specific as to geographic area and provider specialty. Any provider not selected by the health |
23 | plan may be placed on a waiting list. |
24 | (ii) This credentialing process shall begin upon acceptance of an application from a |
25 | provider to the plan for inclusion. |
26 | (iii) Each application shall be reviewed by the plan's credentialing body. |
27 | (iv) All health plans shall develop and maintain credentialing criteria to be utilized in |
28 | adding providers from the plans' network. Credentialing criteria shall be based on input from |
29 | providers credentialed in the plan and these standards shall be available to applicants. When |
30 | economic considerations are part of the decisions, the criteria must be available to applicants. |
31 | Any economic profiling must factor the specialty utilization and practice patterns and general |
32 | information comparing the applicant to his or her peers in the same specialty will be made |
33 | available. Any economic profiling of providers must be adjusted to recognize case mix, severity |
34 | of illness, age of patients and other features of a provider's practice that may account for higher |
| LC005936/SUB A - Page 23 of 45 |
1 | than or lower than expected costs. Profiles must be made available to those so profiled. |
2 | (7) A health plan shall not exclude a provider of covered services from participation in |
3 | its provider network based solely on: |
4 | (i) The provider's degree or license as applicable under state law; or |
5 | (ii) The provider of covered services lack of affiliation with, or admitting privileges at a |
6 | hospital, if that lack of affiliation is due solely to the provider's type of license. |
7 | (8) Health plans shall not discriminate against providers solely because the provider |
8 | treats a substantial number of patients who require expensive or uncompensated medical care. |
9 | (9) The applicant shall be provided with all reasons used if the application is denied. |
10 | (10) Plans shall not be allowed to include clauses in physician or other provider contracts |
11 | that allow for the plan to terminate the contract "without cause"; provided, however, cause shall |
12 | include lack of need due to economic considerations. |
13 | (11) (i) There shall be due process for non-institutional providers for all adverse |
14 | decisions resulting in a change of privileges of a credentialed non-institutional provider. The |
15 | details of the health plan's due process shall be included in the plan's provider contracts. |
16 | (ii) A health plan is deemed to have met the adequate notice and hearing requirement of |
17 | this section with respect to a non-institutional provider if the following conditions are met (or are |
18 | waived voluntarily by the non-institutional provider): |
19 | (A) The provider shall be notified of the proposed actions and the reasons for the |
20 | proposed action. |
21 | (B) The provider shall be given the opportunity to contest the proposed action. |
22 | (C) The health plan has developed an internal appeals process that has reasonable time |
23 | limits for the resolution of an internal appeal. |
24 | (12) If the plan places a provider or provider group at financial risk for services not |
25 | provided by the provider or provider group, the plan must require that a provider or group has met |
26 | all appropriate standards of the department of business regulation. |
27 | (13) A health plan shall not include a most favored rate clause in a provider contract. |
28 | 23-17.13-4. Penalties and enforcement. -- (a) The director of the department of health |
29 | may, in lieu of the suspension or revocation of a license, levy an administrative penalty in an |
30 | amount not less than five hundred dollars ($500) nor more than fifty thousand dollars ($50,000), |
31 | if reasonable notice, in writing, is given of the intent to levy the penalty and the particular health |
32 | organization has a reasonable time in which to remedy the defect in its operations which gave rise |
33 | to the penalty citation. The director of health may augment this penalty by an amount equal to the |
34 | sum that the director calculates to be the damages suffered by enrollees or other members of the |
| LC005936/SUB A - Page 24 of 45 |
1 | public. |
2 | (b) Any person who knowingly and willfully violates this chapter shall be guilty of a |
3 | misdemeanor and may be punished by a fine not to exceed five hundred dollars ($500) or by |
4 | imprisonment for a period not exceeding one year, or both. |
5 | (c) (1) If the director of health shall for any reason have cause to believe that any |
6 | violation of this chapter has occurred or is threatened, the director of health may give notice to the |
7 | particular health organization and to their representatives, or other persons who appear to be |
8 | involved in the suspected violation, to arrange a conference with the alleged violators or their |
9 | authorized representatives for the purpose of attempting to ascertain the facts relating to the |
10 | suspected violation, and, in the event it appears that any violation has occurred or is threatened, to |
11 | arrive at an adequate and effective means of correcting or preventing the violation; |
12 | (2) Proceedings under this subsection shall be governed by chapter 35 of title 42. |
13 | (d) (1) The director of health may issue an order directing a particular health |
14 | organization or a representative of that health organization to cease and desist from engaging in |
15 | any act or practice in violation of the provisions of this chapter; |
16 | (2) Within thirty (30) days after service of the order to cease and desist, the respondent |
17 | may request a hearing on the question of whether acts or practices in violation of this chapter |
18 | have occurred. Those hearings shall be conducted pursuant to §§ 42-35-9 through 42-35-13, and |
19 | judicial review shall be available as provided by §§ 42-35-15 and 42-35-16. |
20 | (e) In the case of any violation of the provisions of this chapter, if the director of health |
21 | elects not to issue a cease and desist order, or in the event of noncompliance with a cease and |
22 | desist order issued pursuant to subsection (d), the director of health may institute a proceeding to |
23 | obtain injunctive relief, or seeking other appropriate relief, in the superior court for the county of |
24 | Providence. |
25 | 23-17.13-5. Severability. -- If any section, clause, or provision of this chapter shall be |
26 | held either unconstitutional or ineffective in whole or in part to the extent that it is not |
27 | unconstitutional or ineffective, it shall be valid and effective and no other section, clause or |
28 | provision shall on account thereof be termed invalid or ineffective. |
29 | 23-17.13-6. Contracts with providers for dental services. -- (a) No contract between a |
30 | dental plan of a health care entity and a dentist for the provision of services to patients may |
31 | require that a dentist provide services to its subscribers at a fee set by the health care entity unless |
32 | said services are covered services under the applicable subscriber agreement. "Covered services," |
33 | as used herein, means services reimbursable under the applicable subscriber agreement, subject to |
34 | such contractual limitations on subscriber benefits as may apply, including, for example, |
| LC005936/SUB A - Page 25 of 45 |
1 | deductibles, waiting period or frequency limitations. |
2 | (b) For the purposes of this section "dental plan" shall include any policy of insurance |
3 | which is issued by a health care entity which provides for coverage of dental services not in |
4 | connection with a medical plan. |
5 | 23-17.13-7. Contracts with providers and optometric services. -- (a) No contract |
6 | between an eye care provider and a company offering accident and sickness insurance as defined |
7 | in chapter 18 of title 27; a nonprofit medical service corporation as defined in chapter 20 of title |
8 | 27; or a health maintenance organization as defined in chapter 41 of title 27; or a vision plan, may |
9 | require that an eye care provider provide services or materials to its subscribers at a fee set by the |
10 | insurer or vision plan unless the insurer or vision plan compensates the eye care provider for the |
11 | provision of such services or materials to the patient. Reimbursement paid by the insurer or vision |
12 | plan for covered services and materials shall not provide nominal reimbursement in order to claim |
13 | that services and materials are covered services. |
14 | (b) (1) "Services" means services and materials for which reimbursement from the vision |
15 | plan is provided for by an enrollee's plan contract, or for which a reimbursement would be |
16 | available but for the application of the enrollee's contractual limitations of deductibles, |
17 | copayments, or coinsurance. |
18 | (2) "Materials" means and includes, but is not limited to, lenses, devices containing |
19 | lenses, prisms, lens treatments and coatings, contact lenses, orthoptics, vision training, and |
20 | prosthetic devices to correct, relieve, or treat defects or abnormal conditions of the human eye or |
21 | its adnexa. |
22 | (3) "Eye care provider" means an optometrist, optician, or ophthalmologist. |
23 | SECTION 3. Chapter 23-17.18 of the General Laws entitled "Health Plan Modification |
24 | Act" is hereby repealed in its entirety. |
25 | CHAPTER 23-17.18 |
26 | Health Plan Modification Act |
27 | 23-17.18-1. Modification of health plans. -- (a) A health plan may materially modify the |
28 | terms of a participating agreement it maintains with a physician only if the plan disseminates in |
29 | writing by mail to the physician the contents of the proposed modification and an explanation, in |
30 | nontechnical terms, of the modification's impact. |
31 | (b) The health plan shall provide the physician an opportunity to amend or terminate the |
32 | physician contract with the health plan within sixty (60) days of receipt of the notice of |
33 | modification. Any termination of a physician contract made pursuant to this section shall be |
34 | effective fifteen (15) calendar days from the mailing of the notice of termination in writing by |
| LC005936/SUB A - Page 26 of 45 |
1 | mail to the health plan. The termination shall not affect the method of payment or reduce the |
2 | amount of reimbursement to the physician by the health plan for any patient in active treatment |
3 | for an acute medical condition at the time the patient's physician terminates his, her, or its |
4 | physician contract with the health plan until the active treatment is concluded or, if earlier, one |
5 | year after the termination; and, with respect to the patient, during the active treatment period the |
6 | physician shall be subject to all the terms and conditions of the terminated physician contract, |
7 | including but not limited to, all reimbursement provisions which limit the patient's liability. |
8 | (c) Nothing in this section shall apply to accident-only, specified disease, hospital |
9 | indemnity, Medicare supplement, long-term care, disability income, or other limited benefit |
10 | health insurance policies. |
11 | SECTION 4. Title 27 of the General Laws entitled "INSURANCE" is hereby amended |
12 | by adding thereto the following chapter: |
13 | CHAPTER 18.8 |
14 | HEALTH CARE ACCESSIBILITY AND QUALITY ASSURANCE ACT |
15 | 27-18.8-1. Purpose. -- The legislature declares that: |
16 | (1) It is in the best interest of the public that those individuals and care entities involved |
17 | with the delivery of plan coverage in our state meet the standards of this chapter to insure |
18 | accessibility and quality for the state's patients; |
19 | (2) Nothing in the legislation is intended to prohibit a health care entity or contractor |
20 | from forming limited networks of providers; and |
21 | (3) It is a vital state function to establish these standards for the conduct of health plans |
22 | by a health care entity in Rhode Island. |
23 | 27-18.8-2. Definitions. -- As used in this chapter: |
24 | (1) "Adverse determination" means a utilization review decision by a review agent not to |
25 | authorize a health care service. A decision by a review agent to authorize a health care service in |
26 | an alternative setting, a modified extension of stay, or an alternative treatment shall not constitute |
27 | an adverse determination if the review agent and provider are in agreement regarding the |
28 | decision. Adverse determinations include decisions not to authorize formulary and non-formulary |
29 | medication. |
30 | (2) "Benefit determination" means a decision of the enrollee's entitlement to payment for |
31 | covered health care services as defined in an agreement with the payor or its delegate. |
32 | (3) "Contractor" means a person/entity that: |
33 | (i) Establishes, operates or maintains a network of participating providers; |
34 | (ii) Contracts with an insurance company, a hospital or medical or dental service plan, an |
| LC005936/SUB A - Page 27 of 45 |
1 | employer, whether under written or self insured, an employee organization, or any other entity |
2 | providing coverage for health care services to administer a plan; and/or |
3 | (iii) Conducts or arranges for utilization review activities pursuant to this chapter. |
4 | (4) "Commissioner" means the commissioner of the Office of the Health Insurance |
5 | Commissioner. |
6 | (5) "Emergency services" has the same meaning as the meaning contained in the rules |
7 | and regulations promulgated pursuant to chapter 12.3 of title 42, as may be amended from time to |
8 | time, and includes the sudden onset of a medical or mental condition that the absence of |
9 | immediate medical attention could reasonably be expected to result in placing the patient's health |
10 | in serious jeopardy, serious impairment to bodily or mental functions, or serious dysfunction of |
11 | any bodily organ or part. |
12 | (6) "Health care entity" means a licensed insurance company, hospital, or dental or |
13 | medical service plan or health maintenance organization, or a contractor as described in |
14 | subsection (3) of this section, that operates a health plan. |
15 | (7) "Health care services" includes, but is not limited to, medical, mental health, |
16 | substance abuse, and dental services. |
17 | (8) "Health plan" means a plan operated by a health care entity as described in subsection |
18 | (6) of this section that provides for the delivery of care services to persons enrolled in the plan |
19 | through: |
20 | (i) Arrangements with selected providers to furnish health care services; and/or |
21 | (ii) Financial incentives for persons enrolled in the plan to use the participating providers |
22 | and procedures provided for by the plan. |
23 | (9) "Provider" means a physician, hospital, pharmacy, laboratory, dentist, or other state |
24 | licensed or other state recognized provider of health care services or supplies, and whose services |
25 | are recognized pursuant to 213(d) of the Internal Revenue Code, 26 U.S.C. § 213(d), that has |
26 | entered into an agreement with a health care entity as described in subsection (6) of this section or |
27 | contractor as described in subsection (2) of this section to provide these services or supplies to a |
28 | patient enrolled in a plan. |
29 | (10) "Most favored rate clause" means a provision in a provider contract whereby the |
30 | rates or fees to be paid by a health plan are fixed, established or adjusted to be equal to or lower |
31 | than the rates or fees paid to the provider by any other health plan or third party payor. |
32 | 27-18.8-3. Certification of health plans. -- (a) Certification process. |
33 | (1) Certification. |
34 | (i) The commissioner, in consultation with the director of the department of health, shall |
| LC005936/SUB A - Page 28 of 45 |
1 | establish a process for certification of health plans meeting the requirements of certification in |
2 | subsection (b) of this section. |
3 | (ii) The commissioner shall act upon the health plan's completed application for |
4 | certification within ninety (90) days of receipt of such application for certification. |
5 | (2) Review and recertification. To ensure compliance with subsection (b) of this section, |
6 | the commissioner shall establish procedures for the periodic review and recertification of health |
7 | plans not less than every five (5) years; provided, however, that the commissioner may review the |
8 | certification of a health plan at any time if there exists evidence that a health plan may be in |
9 | violation of subsection (b) of this section. |
10 | (3) Cost of certification. The total cost of obtaining and maintaining certification under |
11 | this title and compliance with the requirements of the applicable rules and regulations are borne |
12 | by the entities so certified and shall be one hundred and fifty percent (150%) of the total salaries |
13 | paid to the certifying personnel of the office engaged in those certifications less any salary |
14 | reimbursements and shall be paid to the commissioner to and for the use of the office. That |
15 | assessment shall be in addition to any taxes and fees otherwise payable to the state. |
16 | (b) Requirements for certification. The commissioner, in consultation with the director of |
17 | the department of health, shall establish standards and procedures for the certification of health |
18 | plans that conduct business in this state and who have demonstrated the ability to ensure that |
19 | health care services will be provided in a manner to assure availability and accessibility, adequate |
20 | personnel and facilities, and continuity of service, and has demonstrated arrangements for |
21 | ongoing quality assurance programs regarding care processes and outcomes; other standards shall |
22 | consist of, but are not limited to, the following: |
23 | (1) Plans must demonstrate that: |
24 | (i) They have reasonable access to providers, so that all covered health care services will |
25 | be provided. This requirement cannot be waived and must be met in all areas where the health |
26 | plan has enrollees; |
27 | (ii) Covered health care services shall be available within a time frame that meets |
28 | standards set by the commissioner. |
29 | (2) A comprehensive list of participating providers listed by office location, specialty if |
30 | applicable, and other information as determined by the commissioner, updated annually. |
31 | (c) Issuance of certification. |
32 | (1) A health care plan shall meet all or some of the requirements of certification, by |
33 | providing the required certification information to any state or federal agency in conformance |
34 | with any other applicable state or federal law, or in conformity with standards adopted by an |
| LC005936/SUB A - Page 29 of 45 |
1 | accrediting organization provided that the commissioner determines that the information is |
2 | substantially similar to the previously mentioned requirements. |
3 | (2) All health plans shall be required to establish a mechanism, under which providers, |
4 | including local providers participating in the plan, provide input into the plan's health care policy, |
5 | including technology, medications and procedures, utilization review criteria and procedures, |
6 | quality and credentialing criteria, and medical management procedures. |
7 | (2) All health plans shall be required to establish a mechanism under which local |
8 | individual subscribers to the plan provide input into the plan's procedures and processes regarding |
9 | the delivery of health care services. |
10 | (3) A health plan shall not refuse to contract with or compensate for covered services an |
11 | otherwise eligible provider or non-participating provider solely because that provider has in good |
12 | faith communicated with one or more of their patients regarding the provisions, terms or |
13 | requirements of the insurer's products as they relate to the needs of that provider's patients. |
14 | (4) The health plan provider contracting and credentialing process shall include the |
15 | following: |
16 | (i) This credentialing process shall begin upon acceptance of an application from a |
17 | provider to the plan for inclusion. |
18 | (ii) Each application shall be reviewed by the plan's credentialing body. |
19 | (iii) All health plans shall develop and maintain credentialing criteria to be utilized in |
20 | adding providers from the plans' network. Credentialing criteria shall be based on input from |
21 | providers credentialed in the plan and these standards shall be available to applicants. When |
22 | economic considerations are part of the decisions, the criteria must be available to applicants. |
23 | Any economic profiling must factor the specialty utilization and practice patterns and general |
24 | information comparing the applicant to their peers in the same specialty will be made available. |
25 | Any economic profiling of providers must be adjusted to recognize case mix, severity of illness, |
26 | age of patients and other features of a provider's practice that may account for higher than or |
27 | lower than expected costs. Profiles must be made available to those so profiled. |
28 | (5) A health plan shall not exclude a provider of covered services from participation in its |
29 | provider network based solely on: |
30 | (i) The provider's degree or license as applicable under state law; or |
31 | (ii) The provider of covered services lack of affiliation with, or admitting privileges at a |
32 | hospital, if that lack of affiliation is due solely to the provider's type of license. |
33 | (6) Health plans shall not discriminate against providers solely because the provider treats |
34 | a substantial number of patients who require expensive or uncompensated medical care. |
| LC005936/SUB A - Page 30 of 45 |
1 | (7) The applicant shall be provided with all reasons used if the application is denied. |
2 | (8) Plans shall not be allowed to include clauses in physician or other provider contracts |
3 | that allow for the plan to terminate the contract "without cause"; provided, however, cause shall |
4 | include lack of need due to economic considerations. |
5 | (9)(i) There shall be due process for non-institutional providers for all adverse decisions |
6 | resulting in a change of privileges of a credentialed non-institutional provider. The details of the |
7 | health plan's due process shall be included in the plan's provider contracts. |
8 | (ii) A health plan is deemed to have met the adequate notice and hearing requirement of |
9 | this section with respect to a non-institutional provider if the following conditions are met (or are |
10 | waived voluntarily by the non-institutional provider): |
11 | (A) The provider shall be notified of the proposed actions and the reasons for the |
12 | proposed action. |
13 | (B) The provider shall be given the opportunity to contest the proposed action. |
14 | (C) The health plan has developed an internal appeals process that has reasonable time |
15 | limits for the resolution of an internal appeal. |
16 | (10) A health plan shall not include a most favored rate clause in a provider contract. |
17 | (11) A health plan may materially modify the terms of a participating agreement it |
18 | maintains with a physician only if the plan disseminates in writing by mail to the physician the |
19 | contents of the proposed modification and an explanation, in nontechnical terms, of the |
20 | modification's impact. |
21 | (12) The health plan shall provide the physician an opportunity to amend or terminate the |
22 | physician contract with the health plan within sixty (60) days of receipt of the notice of |
23 | modification. Any termination of a physician contract made pursuant to this section shall be |
24 | effective fifteen (15) calendar days from the mailing of the notice of termination in writing by |
25 | mail to the health plan. The termination shall not affect the method of payment or reduce the |
26 | amount of reimbursement to the physician by the health plan for any patient in active treatment |
27 | for an acute medical condition at the time the patient's physician terminates their physician |
28 | contract with the health plan until the active treatment is concluded or, if earlier, one year after |
29 | the termination; and, with respect to the patient, during the active treatment period the physician |
30 | shall be subject to all the terms and conditions of the terminated physician contract, including but |
31 | not limited to, all reimbursement provisions which limit the patient's liability. |
32 | 27-18.8-4. Contracts with providers for dental services. -- (a) No contract between a |
33 | dental plan of a health care entity and a dentist for the provision of services to patients may |
34 | require that a dentist provide services to its subscribers at a fee set by the health care entity unless |
| LC005936/SUB A - Page 31 of 45 |
1 | said services are covered services under the applicable subscriber agreement. "Covered services," |
2 | as used herein, means services reimbursable under the applicable subscriber agreement, subject to |
3 | such contractual limitations on subscriber benefits as may apply, including, for example, |
4 | deductibles, waiting period or frequency limitations. |
5 | (b) For the purposes of this section "dental plan" shall include any policy of insurance |
6 | which is issued by a health care entity which provides for coverage of dental services not in |
7 | connection with a medical plan. |
8 | 27-18.8-5. Contracts with providers and optometric services. -- (a) No contract |
9 | between an eye care provider and a company offering accident and sickness insurance as defined |
10 | in chapter 18 of title 27; a nonprofit medical service corporation as defined in chapter 20 of title |
11 | 27; or a health maintenance organization as defined in chapter 41 of title 27; or a vision plan, may |
12 | require that an eye care provider provide services or materials to its subscribers at a fee set by the |
13 | insurer or vision plan unless the insurer or vision plan compensates the eye care provider for the |
14 | provision of such services or materials to the patient. Reimbursement paid by the insurer or vision |
15 | plan for covered services and materials shall not provide nominal reimbursement in order to claim |
16 | that services and materials are covered services. |
17 | (b)(1) "Services" means services and materials for which reimbursement from the vision |
18 | plan is provided for by an enrollee's plan contract, or for which a reimbursement would be |
19 | available but for the application of the enrollee's contractual limitations of deductibles, |
20 | copayments, or coinsurance. |
21 | (2) "Materials" means and includes, but is not limited to, lenses, devices containing |
22 | lenses, prisms, lens treatments and coatings, contact lenses, orthoptics, vision training, and |
23 | prosthetic devices to correct, relieve, or treat defects or abnormal conditions of the human eye or |
24 | its adnexa. |
25 | (3) "Eye care provider" means an optometrist, optician, or ophthalmologist. |
26 | 27-18.8-6. Penalties and enforcement. -- (a) The commissioner may, in lieu of the |
27 | suspension or revocation of a license, levy an administrative penalty in an amount not less than |
28 | five hundred dollars ($500) nor more than fifty thousand dollars ($50,000), if reasonable notice, |
29 | in writing, is given of the intent to levy the penalty and the particular health organization has a |
30 | reasonable time in which to remedy the defect in its operations which gave rise to the penalty |
31 | citation. The commissioner may augment this penalty by an amount equal to the sum that the |
32 | commissioner calculates to be the damages suffered by enrollees or other members of the public. |
33 | (b) Any person who knowingly and willfully violates this chapter shall be guilty of a |
34 | misdemeanor and may be punished by a fine not to exceed five hundred dollars ($500) or by |
| LC005936/SUB A - Page 32 of 45 |
1 | imprisonment for a period not exceeding one year, or both. |
2 | (c)(1) If the commissioner shall for any reason have cause to believe that any violation of |
3 | this chapter has occurred or is threatened, the commissioner may give notice to the particular |
4 | health organization and to their representatives, or other persons who appear to be involved in the |
5 | suspected violation, to arrange a conference with the alleged violators or their authorized |
6 | representatives for the purpose of attempting to ascertain the facts relating to the suspected |
7 | violation, and, in the event it appears that any violation has occurred or is threatened, to arrive at |
8 | an adequate and effective means of correcting or preventing the violation; |
9 | (2) Proceedings under this subsection shall be governed by chapter 35 of title 42. |
10 | (d)(1) The commissioner may issue an order directing a particular health organization or |
11 | a representative of that health organization to cease and desist from engaging in any act or |
12 | practice in violation of the provisions of this chapter; |
13 | (2) Within thirty (30) days after service of the order to cease and desist, the respondent |
14 | may request a hearing on the question of whether acts or practices in violation of this chapter |
15 | have occurred. Those hearings shall be conducted pursuant to §§ 42-35-9 through 42-35-13, and |
16 | judicial review shall be available as provided by §§ 42-35-15 and 42-35-16. |
17 | (e) In the case of any violation of the provisions of this chapter, if the commissioner |
18 | elects not to issue a cease and desist order, or in the event of noncompliance with a cease and |
19 | desist order issued pursuant to subsection (d) of this section, the commissioner may institute a |
20 | proceeding to obtain injunctive relief, or seeking other appropriate relief, in the superior court for |
21 | the county of Providence. |
22 | 27-18.8-7. Severability. -- If any section, clause, or provision of this chapter shall be |
23 | held either unconstitutional or ineffective in whole or in part to the extent that it is not |
24 | unconstitutional or ineffective, it shall be valid and effective and no other section, clause or |
25 | provision shall on account thereof be termed invalid or ineffective. |
26 | SECTION 5. Title 27 of the General Laws entitled "INSURANCE" is hereby amended |
27 | by adding thereto the following chapter: |
28 | CHAPTER 18.9 |
29 | HEALTH CARE SERVICES -- UTILIZATION REVIEW ACT |
30 | 27-18.9-1. Purpose of chapter. -- The purpose of the chapter is to: |
31 | (1) Promote the delivery of quality health care in a cost effective manner; |
32 | (2) Foster greater coordination between health care providers, patients, payors and |
33 | utilization review entities; |
34 | (3) Protect patients, businesses, and providers by ensuring that review agents are |
| LC005936/SUB A - Page 33 of 45 |
1 | qualified to perform utilization review activities and to make informed decisions on the |
2 | appropriateness of medical care; and |
3 | (4) Ensure that review agents maintain the confidentiality of medical records in |
4 | accordance with applicable state and federal laws. |
5 | (5) Provide for consultation by the department of health to the office of the health |
6 | insurance commissioner in furtherance of the purposes of this chapter. |
7 | 27-18.9-2. Definitions. -- As used in this chapter, the following terms are defined as |
8 | follows: |
9 | (1) "Adverse determination" means a utilization review decision by a review agent not to |
10 | authorize a health care service. A decision by a review agent to authorize a health care service in |
11 | an alternative setting, a modified extension of stay, or an alternative treatment shall not constitute |
12 | an adverse determination if the review agent and provider are in agreement regarding the |
13 | decision. Adverse determinations include decisions not to authorize formulary and non-formulary |
14 | medication. |
15 | (2) "Appeal" means a subsequent review of an adverse determination upon request by a |
16 | patient or provider to reconsider all or part of the original decision. |
17 | (3) "Authorization" means the review agent's utilization review, performed according to § |
18 | 27-18.9-2(20), concluded that the allocation of health care services of a provider, given or |
19 | proposed to be given to a patient was approved or authorized. |
20 | (4) "Benefit determination" means a decision of the enrollee's entitlement to payment for |
21 | covered health care services as defined in an agreement with the payor or its delegate. |
22 | (5) "Certificate" means a certificate of registration granted by the commissioner to a |
23 | review agent. |
24 | (6) "Complaint" means a written expression of dissatisfaction by a patient, or provider. |
25 | The appeal of an adverse determination is not considered a complaint. |
26 | (7) "Concurrent assessment" means an assessment of the medical necessity and/or |
27 | appropriateness of health care services conducted during a patient's hospital stay or course of |
28 | treatment. If the medical problem is ongoing, this assessment may include the review of services |
29 | after they have been rendered and billed. |
30 | (8) "Office" means the office of the health insurance commissioner. |
31 | (9) "Commissioner" means the health insurance commissioner. |
32 | (10) "Emergent health care services" has the same meaning as that meaning contained in |
33 | the rules and regulations promulgated pursuant to chapter 12.3 of title 42 as may be amended |
34 | from time to time and includes those resources provided in the event of the sudden onset of a |
| LC005936/SUB A - Page 34 of 45 |
1 | medical, mental health, or substance abuse or other health care condition manifesting itself by |
2 | acute symptoms of a severity (e.g. severe pain) where the absence of immediate medical attention |
3 | could reasonably be expected to result in placing the patient's health in serious jeopardy, serious |
4 | impairment to bodily or mental functions, or serious dysfunction of any body organ or part. |
5 | (11) "Patient" means an enrollee or participant in all hospital or medical plans seeking |
6 | health care services and treatment from a provider. |
7 | (12) "Payor" means a health insurer, self-insured plan, nonprofit health service plan, |
8 | health insurance service organization, preferred provider organization, health maintenance |
9 | organization or other entity authorized to offer health insurance policies or contracts or pay for |
10 | the delivery of health care services or treatment in this state. |
11 | (13) "Practitioner" means any person licensed to provide or otherwise lawfully providing |
12 | health care services, including, but not limited to, a physician, dentist, nurse, optometrist, |
13 | podiatrist, physical therapist, clinical social worker, or psychologist. |
14 | (14) "Prospective assessment" means an assessment of the medical necessity and/or |
15 | appropriateness of health care services prior to services being rendered. |
16 | (15) "Provider" means any health care facility, as defined in § 23-17-2 including any |
17 | mental health and/or substance abuse treatment facility, physician, or other licensed practitioners |
18 | identified to the review agent as having primary responsibility for the care, treatment, and |
19 | services rendered to a patient. |
20 | (16) "Retrospective assessment" means an assessment of the medical necessity and/or |
21 | appropriateness of health care services that have been rendered. This shall not include reviews |
22 | conducted when the review agency has been obtaining ongoing information. |
23 | (17) "Review agent" means a person or entity or insurer performing utilization review |
24 | that is either employed by, affiliated with, under contract with, or acting on behalf of: |
25 | (i) A business entity doing business in this state; |
26 | (ii) A party that provides or administers health care benefits to citizens of this state, |
27 | including a health insurer, self-insured plan, nonprofit health service plan, health insurance |
28 | service organization, preferred provider organization or health maintenance organization |
29 | authorized to offer health insurance policies or contracts or pay for the delivery of health care |
30 | services or treatment in this state; or |
31 | (iii) A provider not involved in the care of the patient. |
32 | (18) "Same or similar specialty" means a practitioner who has the appropriate training |
33 | and experience that is the same or similar as the attending provider in addition to experience in |
34 | treating the same problems to include any potential complications as those under review. |
| LC005936/SUB A - Page 35 of 45 |
1 | (19) "Urgent health care services" has the same meaning as that meaning contained in the |
2 | rules and regulations promulgated pursuant to chapter 12.3 of title 42 as may be amended from |
3 | time to time and includes those resources necessary to treat a symptomatic medical, mental |
4 | health, or substance abuse or other health care condition requiring treatment within a twenty-four |
5 | (24) hour period of the onset of such a condition in order that the patient's health status not |
6 | decline as a consequence. This does not include those conditions considered to be emergent |
7 | health care services as defined in subsection (10) of this section. |
8 | (20) "Utilization review" means the prospective, concurrent, or retrospective assessment |
9 | of the necessity and/or appropriateness of the allocation of health care services of a provider, |
10 | given or proposed to be given to a patient. Utilization review does not include: |
11 | (i) Elective requests for the clarification of coverage; or |
12 | (ii) Benefit determination; or |
13 | (iii) Claims review that does not include the assessment of the medical necessity and |
14 | appropriateness; or |
15 | (iv) A provider's internal quality assurance program except if it is associated with a health |
16 | care financing mechanism; or |
17 | (v) The therapeutic interchange of drugs or devices by a pharmacy operating as part of a |
18 | licensed inpatient health care facility; or |
19 | (vi) The assessment by a pharmacist licensed pursuant to the provisions of chapter 19 of |
20 | title 5 and practicing in a pharmacy operating as part of a licensed inpatient health care facility in |
21 | the interpretation, evaluation and implementation of medical orders, including assessments and/or |
22 | comparisons involving formularies and medical orders. |
23 | (21) "Utilization review plan" means a description of the standards governing utilization |
24 | review activities performed by a private review agent. |
25 | (22) "Health care services" means and includes an admission, diagnostic procedure, |
26 | therapeutic procedure, treatment, extension of stay, the ordering and/or filling of formulary or |
27 | non-formulary medications, and any other services, activities, or supplies that are covered by the |
28 | patient's benefit plan. |
29 | (23) "Therapeutic interchange" means the interchange or substitution of a drug with a |
30 | dissimilar chemical structure within the same therapeutic or pharmacological class that can be |
31 | expected to have similar outcomes and similar adverse reaction profiles when given in equivalent |
32 | doses, in accordance with protocols approved by the president of the medical staff or medical |
33 | director and the director of pharmacy. |
34 | 27-18.9-3. General requirements. -- (a) A review agent shall not conduct utilization |
| LC005936/SUB A - Page 36 of 45 |
1 | review in the state unless the office has granted the review agent a certificate. |
2 | (b) Individuals shall not be required to hold separate certification under this chapter when |
3 | acting as either an employee of, an affiliate of, a contractor for, or otherwise acting on behalf of a |
4 | certified review agent. |
5 | (c) The office shall issue a certificate to an applicant that has met the minimum standards |
6 | established by this chapter, and regulations promulgated in accordance with it, including the |
7 | payment of any fees as required, and other applicable regulations of the office. |
8 | (d) A certificate issued under this chapter is not transferable, and the transfer of fifty |
9 | percent (50%) or more of the ownership of a review agent shall be deemed a transfer. |
10 | (e) After consultation with the payors and providers of health care, the office shall adopt |
11 | regulations necessary to implement the provisions of this chapter. |
12 | (f) The commissioner is authorized to establish any fees for initial application, renewal |
13 | applications, and any other administrative actions deemed necessary by the commissioner to |
14 | implement this chapter. |
15 | (g) The total cost of certification under this title shall be borne by the certified entities |
16 | and shall be one hundred fifty percent (150%) of the total salaries paid to the certifying personnel |
17 | of the office engaged in those certifications less any salary reimbursements and shall be paid to |
18 | the commissioner to and for the use of the office. That assessment shall be in addition to any |
19 | taxes and fees otherwise payable to the state, and shall be paid to the commissioner to and for the |
20 | use of the office. |
21 | (h) The application and other fees required under this chapter shall be sufficient to pay |
22 | for the administrative costs of the certificate program and any other reasonable costs associated |
23 | with carrying out the provisions of this chapter. |
24 | (i) A certificate expires on the third anniversary of its effective date unless the certificate |
25 | is renewed for a three (3) year term as provided in this chapter. |
26 | (j) Any systemic changes in the review agents operations relative to certification |
27 | information on file shall be submitted to the office for approval within thirty (30) days prior to |
28 | implementation. For purposes of this chapter, systemic changes are further defined in regulation. |
29 | 27-18.9-4. General application requirements. -- An application for certification or |
30 | recertification shall be accompanied by documentation to evidence the following: |
31 | (1) The requirement that the review agent provide patients and providers with a summary |
32 | of its utilization review plan including a summary of the standards, procedures and methods to be |
33 | used in evaluating proposed or delivered health care services; |
34 | (2) The circumstances, if any, under which utilization review may be delegated to any |
| LC005936/SUB A - Page 37 of 45 |
1 | other utilization review program and evidence that the delegated agency is a certified utilization |
2 | review agency delegated to perform utilization review pursuant to all of the requirements of this |
3 | chapter; |
4 | (3) A complaint resolution process consistent with § 27-18.9-2(6) and acceptable to the |
5 | office, whereby patients, their physicians, or other health care providers may seek resolution of |
6 | complaints and other matters of which the review agent has received written notice; |
7 | (4) The type and qualifications of personnel (employed or under contract) authorized to |
8 | perform utilization review, including a requirement that only a practitioner with the same license |
9 | status as the ordering practitioner, or a licensed physician or dentist, is permitted to make a |
10 | prospective or concurrent adverse determination; |
11 | (5) The requirement that a representative of the review agent is reasonably accessible to |
12 | patients, patient's family and providers at least five (5) days a week during normal business in |
13 | Rhode Island and during the hours of the agency's review operations; |
14 | (6) The policies and procedures to ensure that all applicable state and federal laws to |
15 | protect the confidentiality of individual medical records are followed; |
16 | (7) The policies and procedures regarding the notification and conduct of patient |
17 | interviews by the review agent; |
18 | (8) The requirement that no employee of, or other individual rendering an adverse |
19 | determination for, a review agent may receive any financial incentives based upon the number of |
20 | denials of certification made by that employee or individual; |
21 | (9) The requirement that the utilization review agent shall not impede the provision of |
22 | health care services for treatment and/or hospitalization or other use of a provider's services or |
23 | facilities for any patient; |
24 | (10) Evidence that the review agent has not entered into a compensation agreement or |
25 | contract with its employees or agents whereby the compensation of its employees or its agents is |
26 | based upon a reduction of services or the charges for those services, the reduction of length of |
27 | stay, or utilization of alternative treatment settings; provided, nothing in this chapter shall prohibit |
28 | agreements and similar arrangements; and |
29 | (11) An adverse determination and internal appeals process consistent with § 27-18.9-8 |
30 | and acceptable to the office, whereby patients, their physicians, or other health care providers |
31 | may seek prompt reconsideration or appeal of adverse determinations by the review agent. |
32 | 27-18.9-5. Denial, suspension, or revocation of certificate. -- (a) The office may deny a |
33 | certificate upon review of the application if, upon review of the application, it finds that the |
34 | applicant proposing to conduct utilization review does not meet the standards required by this |
| LC005936/SUB A - Page 38 of 45 |
1 | chapter or by any regulations promulgated pursuant to this chapter. |
2 | (b) The office may revoke a certificate and/or impose reasonable monetary penalties not |
3 | to exceed five thousand dollars ($5,000) per violation in any case in which: |
4 | (1) The review agent fails to comply substantially with the requirements of this chapter or |
5 | of regulations adopted pursuant to this chapter; |
6 | (2) The review agent fails to comply with the criteria used by it in its application for a |
7 | certificate; or |
8 | (3) The review agent refuses to permit examination by the commissioner to determine |
9 | compliance with the requirements of this chapter and regulations promulgated pursuant to the |
10 | authority granted to the commissioner in this chapter; provided, however, that the examination |
11 | shall be subject to the confidentiality and "need to know" provisions of §§ 27-18.9-8 (c)(4) and |
12 | (c)(5). These determinations may involve consideration of any written grievances filed with the |
13 | office against the review agent by patients or providers. |
14 | (c) Any applicant or certificate holder aggrieved by an order or a decision of the office |
15 | made under this chapter without a hearing may, within thirty (30) days after notice of the order or |
16 | decision, make a written request to the office for a hearing on the order or decision pursuant to § |
17 | 42-35-15. |
18 | (d) The procedure governing hearings authorized by this section shall be in accordance |
19 | with §§ 42-35-9 through 42-35-13 as stipulated in § 42-35-14(a). A full and complete record shall |
20 | be kept of all proceedings, and all testimony shall be recorded but need not be transcribed unless |
21 | the decision is appealed pursuant to § 42-35-15. A copy or copies of the transcript may be |
22 | obtained by any interested party upon payment of the cost of preparing the copy or copies. |
23 | Witnesses may be subpoenaed by either party. |
24 | 27-18.9-6. Judicial review. -- Any person who has exhausted all administrative remedies |
25 | available to him or her within the office, and who is aggrieved by a final decision of the office |
26 | under § 27-18.9-5, is entitled to judicial review pursuant to §§ 42-35-15 and 42-35-16. |
27 | 27-18.9-7. Waiver of requirements. -- (a) The commissioner may waive all or part of |
28 | the requirements of this chapter if the agent maintains and provides evidence of accreditation by |
29 | an organization that has been approved by the commissioner and in accordance with regulation. |
30 | (b) The office shall waive the requirements of this chapter only when a conflict exists |
31 | with those activities of a review agent that are conducted pursuant to contracts with the state or |
32 | the federal government or those activities under other state or federal jurisdictions. |
33 | (c) The office shall waive de minimus activity, in accordance with the regulations |
34 | adopted by the commissioner. |
| LC005936/SUB A - Page 39 of 45 |
1 | 27-18.9-7.1. Variance of statutory requirements. -- Statutory variances shall be issued |
2 | for a period not to exceed one year and may be subject to such terms and conditions deemed |
3 | necessary as determined by the commissioner. Prior to issuing a statutory variance the office shall |
4 | provide notice and public hearing to ensure necessary patient and health care provider protections |
5 | in the process. |
6 | 27-18.9-8. Review agency requirement for adverse determination and internal |
7 | appeals. -- (a) The adverse determination and appeals process of the review agent shall conform |
8 | to the following: |
9 | (1) Notification of a prospective adverse determination by the review agent shall be |
10 | mailed or otherwise communicated to the provider of record and to the patient or other |
11 | appropriate individual as follows: |
12 | (i) Within fifteen (15) calendar days of receipt of all the information necessary to |
13 | complete a review of non-urgent and/or non-emergent services; |
14 | (ii) Within seventy-two (72) hours of receipt of all the information necessary to complete |
15 | a review of urgent and/or emergent services; and |
16 | (iii) Prior to the expected date of service. |
17 | (2) Notification of a concurrent adverse determination shall be mailed or otherwise |
18 | communicated to the patient and to the provider of record period as follows: |
19 | (i) To the provider(s) prior to the end of the current certified period; and |
20 | (ii) To the patient within one business day of making the adverse determination. |
21 | (3) Notification of a retrospective adverse determination shall be mailed or otherwise |
22 | communicated to the patient and to the provider of record within thirty (30) calendar days of |
23 | receipt of a request for payment with all supporting documentation for the covered benefit being |
24 | reviewed. |
25 | (4) A utilization review agency shall not retrospectively deny authorization for health |
26 | care services provided to a covered person when an authorization has been obtained for that |
27 | service from the review agent unless the approval was based upon inaccurate information |
28 | material to the review or the health care services were not provided consistent with the provider's |
29 | submitted plan of care and/or any restrictions included in the prior approval granted by the review |
30 | agent. |
31 | (5) Any notice of an adverse determination shall include: |
32 | (i) The principal reasons for the adverse determination, to include explicit documentation |
33 | of the criteria not met and/or the clinical rationale utilized by the agency's clinical reviewer in |
34 | making the adverse determination. The criteria shall be in accordance with the agency criteria |
| LC005936/SUB A - Page 40 of 45 |
1 | noted in § 27-18.9-8(d) and shall be made available within the first level appeal timeframe if |
2 | requested unless otherwise provided as part of the adverse determination notification process; |
3 | (ii) The procedures to initiate an appeal of the adverse determination, including the name |
4 | and telephone number of the person to contract with regard to an appeal; |
5 | (iii) The necessary contact information to complete the two-way direct communication |
6 | defined in § 27-18.9-8(a)(7); and |
7 | (iv) The information noted in § 27-18.9-8(a)(5)(i)(ii)(iii) for all verbal notifications |
8 | followed by written notification to the patient and provider(s). |
9 | (6) All initial retrospective adverse determinations of a health care service that had been |
10 | ordered by a physician, dentist or other practitioner shall be made, documented and signed |
11 | consistent with the regulatory requirements which shall be developed by the office with the input |
12 | of review agents, providers and other affected parties. |
13 | (7) A level one appeal decision of an adverse determination shall not be made until an |
14 | appropriately qualified and licensed review physician, dentist or other practitioner has spoken to, |
15 | or otherwise provided for, an equivalent two-way direct communication with the patient's |
16 | attending physician, dentist, other practitioner, other designated or qualified professional or |
17 | provider responsible for treatment of the patient concerning the medical care, with the exception |
18 | of the following: |
19 | (i) When the attending provider is not reasonably available; |
20 | (ii) When the attending provider chooses not to speak with agency staff; |
21 | (iii) When the attending provider has negotiated an agreement with the review agent for |
22 | alternative care; and/or |
23 | (iv) When the attending provider requests a peer to peer communication prior to the |
24 | adverse determination, the review agency shall then comply with § 27-18.9-8(c)(1) in responding |
25 | to such a request. Such requests shall be on the case specific basis unless otherwise arranged for |
26 | in advance by the provider. |
27 | (8) All initial, prospective and concurrent adverse determinations of a health care service |
28 | that had been ordered by a physician, dentist or other practitioner shall be made, documented and |
29 | signed by a licensed practitioner with the same licensure status as the ordering practitioner or a |
30 | licensed physician or dentist. This does not prohibit appropriately qualified review agency staff |
31 | from engaging in discussions with the attending provider, the attending provider's designee or |
32 | appropriate health care facility and office personnel regarding alternative service and treatment |
33 | options. Such a discussion shall not constitute an adverse determination provided though that any |
34 | change to the provider's original order and/or any decision for an alternative level of care must be |
| LC005936/SUB A - Page 41 of 45 |
1 | made and/or appropriately consented to by the attending provider or the provider's designee |
2 | responsible for treating the patient. |
3 | (9) The requirement that, upon written request made by or on behalf of a patient, any |
4 | adverse determination and/or appeal shall include the written evaluation and findings of the |
5 | reviewing physician, dentist or other practitioner. The review agent is required to accept a verbal |
6 | request made by or on behalf of a patient for any information where a provider or patient can |
7 | demonstrate that a timely response is urgent. |
8 | (b) The review agent shall conform to the following for the appeal of an adverse |
9 | determination: |
10 | (1) The review agent shall maintain and make available a written description of the |
11 | appeal procedure by which either the patient or the provider of record may seek review of |
12 | determinations not to authorize a health care service. The process established by each review |
13 | agent may include a reasonable period within which an appeal must be filed to be considered and |
14 | that period shall not be less than one hundred eighty (180) days of receipt of the adverse |
15 | determination. |
16 | (2) The review agent shall notify, in writing, the patient and provider of record of its |
17 | decision on the appeal as soon as practical, but in no case later than fifteen (15) or twenty-one |
18 | (21) business days if verbal notice is given within fifteen (15) business days after receiving the |
19 | required documentation on the appeal. |
20 | (3) The review agent shall also provide for an expedited appeals process for emergency |
21 | or life threatening situations. Each review agent shall complete the adjudication of expedited |
22 | appeals within two (2) business days or seventy-two (72) hours, whichever occurs sooner, of the |
23 | date the appeal is filed and all information necessary to complete the appeal is received by the |
24 | review agent. |
25 | (4) All first level appeals of determinations not to authorize a health care service that had |
26 | been ordered by a physician, dentist, or other practitioner shall be made, documented, and signed |
27 | by a licensed practitioner with the same licensure status as the ordering practitioner or a licensed |
28 | physician or a licensed dentist. |
29 | (5) All second level appeal decisions shall be made, signed, and documented by a |
30 | licensed practitioner in the same or a similar general specialty as typically manages the medical |
31 | condition, procedure, or treatment under discussion. |
32 | (6) The review agent shall maintain records of written appeals and their resolution, and |
33 | shall provide reports as requested by the office. |
34 | (c) The review agency must conform to the following requirements when making its |
| LC005936/SUB A - Page 42 of 45 |
1 | adverse determination and appeal decisions: |
2 | (1) The review agent must assure that the licensed practitioner or licensed physician is |
3 | reasonably available to review the case as required under § 27-18.9-8(a)(7) and shall conform to |
4 | the following: |
5 | (i) Each agency peer reviewer shall have access to and review all necessary information |
6 | as requested by the agency and/or submitted by the provider(s) and/or patients; |
7 | (ii) Each agency shall provide accurate peer review contact information to the provider at |
8 | the time of service, if requested, and/or prior to such service, if requested. This contact |
9 | information must provide a mechanism for direct communication with the agency's peer |
10 | reviewer; |
11 | (iii) Agency peer reviewers shall respond to the provider's request for a two-way direct |
12 | communication defined in § 27-18.9-8(a)(7)(iv) as follows: |
13 | (A) For a prospective review of non-urgent and non-emergent health care services, a |
14 | response within one business day of the request for a peer discussion; |
15 | (B) For concurrent and prospective reviews of urgent and emergent health care services, a |
16 | response within a reasonable period of time of the request for a peer discussion; and |
17 | (C) For retrospective reviews, prior to the first level appeal decision. |
18 | (iv) The review agency will have met the requirements of a two-way direct |
19 | communication, when requested and/or as required prior to the first level of appeal, when it has |
20 | made two (2) reasonable attempts to contact the attending provider directly. |
21 | (v) Repeated violations of this section shall be deemed to be substantial violations |
22 | pursuant to § 27-18.9-5(b) and shall be cause for the imposition of penalties under that section. |
23 | (2) No reviewer at any level under this section shall be compensated or paid a bonus or |
24 | incentive based on making or upholding an adverse determination. |
25 | (3) No reviewer under this section who has been involved in prior reviews of the case |
26 | under appeal or who has participated in the direct care of the patient may participate as the sole |
27 | reviewer in reviewing a case under appeal; provided, however, that when new information has |
28 | been made available at the first level of appeal, then the review may be conducted by the same |
29 | reviewer who made the initial adverse determination. |
30 | (4) A review agent is only entitled to review information or data relevant to the utilization |
31 | review process. A review agent may not disclose or publish individual medical records or any |
32 | confidential medical information obtained in the performance of utilization review activities. A |
33 | review agent shall be considered a third party health insurer for the purposes of § 5-37.3-6(b)(6) |
34 | of this state and shall be required to maintain the security procedures mandated in § 5-37.3-4(c). |
| LC005936/SUB A - Page 43 of 45 |
1 | (5) Notwithstanding any other provision of law, the review agent, the office, and all other |
2 | parties privy to information which is the subject of this chapter shall comply with all state and |
3 | federal confidentiality laws, including, but not limited to, chapter 37.3 of title 5 (Confidentiality |
4 | of Health Care Communications and Information Act) and specifically § 5-37.3-4(c), which |
5 | requires limitation on the distribution of information which is the subject of this chapter on a |
6 | "need to know" basis, and § 40.1-5-26. |
7 | (6) The office may, in response to a complaint that is provided in written form to the |
8 | review agent, review an appeal regarding any adverse determination, and may request |
9 | information of the review agent, provider or patient regarding the status, outcome or rationale |
10 | regarding the decision. |
11 | (d) The review agents clinical criteria used in making its utilization review decisions shall |
12 | comply with the following: |
13 | (i) The requirement that each review agent shall provide its clinical criteria as required |
14 | by law; |
15 | (ii) Written clinical screening criteria and review procedures are established according to |
16 | nationally accepted standards and protocols that are periodically evaluated and updated; and |
17 | (iii) Establish a process to incorporate and consider local variations to national standard |
18 | identified in § 27-18.9-8(d)(ii) above to include input from local participating providers. |
19 | (1) The screening criteria and review procedures must comply with the requirements set |
20 | forth in § 27-18.9-8 (d) and must meet the satisfaction of the commissioner. |
21 | 27-18.9-9. External appeal requirments. -- (a) In cases where the second level of |
22 | appeal to reverse an adverse determination is unsuccessful, the review agent shall provide for an |
23 | external appeal by an unrelated and objective appeal agency, selected by the commissioner. The |
24 | commissioner shall promulgate rules and regulations including, but not limited to, criteria for |
25 | designation, operation, policy, oversight, and termination of designation as an external appeal |
26 | agency. The external appeal agency shall not be required to be certified under this chapter for |
27 | activities conducted pursuant to its designation. |
28 | (b) The external appeal shall have the following characteristics: |
29 | (1) The external appeal review and decision shall be based on the medical necessity for |
30 | the health care or service and the appropriateness of service delivery for which authorization has |
31 | been denied. |
32 | (2) Neutral physicians, dentists, or other practitioners in the same or similar general |
33 | specialty as typically manages the health care service shall be utilized to make the external appeal |
34 | decisions. |
| LC005936/SUB A - Page 44 of 45 |
1 | (3) The neutral physician, dentist, or other practitioner may confer either directly with the |
2 | review agent and provider, or with physicians or dentists appointed to represent them. |
3 | (4) Payment for the appeal fee must not exceed twenty-five dollars ($25.00). It must be |
4 | refunded to the claimant if the adverse benefit determination (or final internal adverse benefit |
5 | determination) is reversed through external review. The fee must be waived if payment of the fee |
6 | would impose an undue financial hardship. In addition, the annual limit on the filing fees for any |
7 | claimant within a single plan year (in the individual market, policy year) must not exceed |
8 | seventy-five dollars ($75.00). Notwithstanding the aforementioned, this subsection shall not |
9 | apply to excepted benefits as defined in 42 U.S.C. 300 gg-91(c). |
10 | (5) The decision of the external appeal agency shall be binding; however, any person who |
11 | is aggrieved by a final decision of the external appeal agency is entitled to judicial review in a |
12 | court of competent jurisdiction. |
13 | 27-18.9-10. Reporting requirements. -- The office, in consultation with the department |
14 | of health, shall establish reporting requirements to determine if the utilization review programs |
15 | are in compliance with the provisions of this chapter and applicable regulations. |
16 | 27-18.9-11. Lists. -- The commissioner shall periodically provide a list of private review |
17 | agents issued certificates and the renewal date for those certificates to all licensed health care |
18 | facilities and any other individual or organization requesting the list. |
19 | 27-18.9-12. Penalties. -- A person who substantially violates any provision of this |
20 | chapter or any regulation adopted under this chapter or who submits any false information in an |
21 | application required by this chapter is guilty of a misdemeanor and on conviction is subject to a |
22 | penalty not exceeding five thousand dollars ($5,000). |
23 | 27-18.9-13. Fees. -- The proceeds of any monetary penalties and fines collected pursuant |
24 | to the provisions of this chapter shall be deposited as general revenues. |
25 | 27-18.9-14. Severability. -- If any provision of this chapter or the application of any |
26 | provision to any person or circumstance shall be held invalid, that invalidity shall not affect the |
27 | provisions or application of this chapter which can be given effect without the invalid provision |
28 | or application, and to this end the provisions of this chapter are declared to be severable. |
29 | SECTION 6. This act shall take effect on January 1, 2017. |
======== | |
LC005936/SUB A | |
======== | |
| LC005936/SUB A - Page 45 of 45 |
EXPLANATION | |
BY THE LEGISLATIVE COUNCIL | |
OF | |
A N A C T | |
RELATING TO HEALTH AND SAFETY - UTILIZATION REVIEW | |
*** | |
1 | This act would transfer Utilization Review (UR) from the department of health |
2 | (HEALTH) to the office of the health insurance commissioner (OHIC). In addition, changes |
3 | would be made to the "Health Care Accessibility and Quality Assurance Act" and the "Health |
4 | Plan Modification Act" to comply with the "Affordable Care Act" to reflect such transfer. |
5 | This act would take effect on January 1, 2017. |
======== | |
LC005936/SUB A | |
======== | |
| LC005936/SUB A - Page 46 of 45 |